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Cis-prenyltransferses (cis-PTases) constitute a family of enzymes involved in the 
synthesis of isoprenoid lipids required for various biological functions across all domains of life. 
The eukaryotic cis-PTase catalyzes the rate-limiting step in the synthesis of dolichyl phosphate, 
an indispensable glycosyl carrier lipid required for protein glycosylation in the lumen of 
endoplasmic reticulum. Based on enzyme composition, cis-PTases can be either homomeric or 
heteromeric enzymes. The human cis-PTase possesses a heteromeric configuration consisting of 
the two evolutionary related subunits: NgBR (dehydrodolichyl diphosphate synthase accessory 
subunit, first identified as a Nogo-B receptor) and DHDDS (dehydrodolichyl diphosphate 
synthase catalytic subunit). Recently, several mutations in both subunits have been reported to 
associate with various human diseases, collectively known as congenital disorders of 
glycosylation (CDG), including severe CDG type I, developmental and epileptic encephalopathy, 
and autosomal recessive retinitis pigmentosa. In addition, mutations on the NgBR subunit have 
been recently reported in patients suffering from early onset of Parkinson’s disease (EOPD).  
Despite its crucial role in the protein glycosylation process, the molecular mechanism of 
heteromeric cis-PTases remains poorly understood due to lack of structural-functional studies on 
these enzymes, in contrast to homodimeric cis-PTases which have been extensively studied. 
Therefore, in this dissertation, I illustrate the first crystal structure of a heteromeric, human cis-
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PTase NgBR/DHDDS complex solved at 2.3 Å. The structure revealed novel features that were 
not previously observed in homodimeric enzymes, including a new dimeric interface formed by a 
unique C-terminus in DHDDS and a novel N-terminal segment in DHDDS serving as a 
membrane sensor for lipid activation. In addition, the structure elucidated the molecular details 
associated with substrate binding, catalysis, and disease-causing mutations. Finally, the structure 
provided novel insights into the mechanism of product chain elongation, an interesting yet one of 
the most enigmatic topics on prenyl chain elongating enzymes. In summary, the crystal structure 
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CHAPTER 1: Introduction 
1.1  Isoprenoid biosynthesis 
Isoprenoids constitutes the largest family of naturally occurring compounds produced by 
living organisms. They serve myriad biological functions such as: quinones used in electron 
transport chain, sterols serving as a structural component of biological membranes and a 
precursor of steroid hormones, photosynthetic pigments (carotenoids, retinoids, and side chain of 
chlorophyll), in protein prenylation important for subcellular targeting, plant hormones including 
gibberellins and abscisic acid, plant terpenoids (mono-, di- and sesqui-terpenes), and polyprenols 
such as dolichols which are employed as sugar carrier lipids during protein glycosylation (1-6). 
Despite their diverse roles, the basic structure of all isoprenoids is formed by the condensation of 
two C5 precursors: isopentenyl diphosphate (IPP) and its isomer dimethylallyl diphosphate 
(DMAPP) (2). In most eukaryotes, archaea, and some eubacteria, IPP and DMAPP are 
synthesized via the mevalonate pathway (MVA), also known as the HMG-CoA reductase 
pathway (7). In contrast, most bacteria and chloroplasts of photosynthetic organisms utilize the 
methylerythritol phosphate (MEP) pathway to generate IPP and DMAPP (8).  
Linear isoprenoids are formed by the condensation of an allylic diphosphate substrate 
with certain number of IPP (homoallylic substrate) units, catalyzed by prenyl chain elongating 
enzymes known as prenyltransferases (6). The newly synthesized products vary in their chain 
length from C10 to C>10,000 (6, 9). With respect to the stereochemistry of the newly formed double 
bond of the product, prenyl-transferases are classified into two categories: trans-
prenyltransferases (trans-PTases) and cis-prenyltransferases (cis-PTases) (2, 10, 11). Although 
both enzyme groups utilize similar substrates, biochemical and biophysical characterization of 
these enzymes revealed major differences in terms of their primary amino acid sequence, three-
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dimensional (3D) structure, and molecular mechanism (6, 12, 13). In this work, however, I will 
focus on the structure and catalytic mechanism of cis-PTase enzymes.  
1.2  Cis-prenyltransferase: enzymatic reaction and classification 
cis-prenyltransferase (cis-PTase) plays a pivotal role in the synthesis of isoprenoids in the 
cis-configuration by catalyzing the sequential condensation of an allylic pyrophosphate primer 
with a variable number of  isopentenyl pyrophosphates (IPP, C5), resulting in the formation of a 
polyprenol pyrophosphate with cis-double bonds (6, 12, 14, 15). The most common type of cis-
PTase catalyzes a “head-to-tail” condensation whereby the newly formed double bond is 
between C1’ of the allylic substrate and C4 of the IPP molecule, thus generating linear 
isoprenoids (10, 16), (SI Appendix, Fig. S1). Recently, few studies have reported homologous of 
cis-PTase catalyzing an unusual “head-to-middle” condensation reaction in which a double bond 
is formed between C1’ of the allylic primer and C2 of the IPP substrate, resulting in the synthesis 
of branched isoprenoids (10, 17, 18). Therefore, isoprenoids are the most structurally diverse, 
naturally occurring compounds with myriad biological functions in all living organisms (2, 6, 
10). In eukaryotes, the cis-PTase localized to the endoplasmic reticulum (ER) is the first enzyme 
committed to dolichol phosphate (Dol-P) biosynthesis (15, 19-22), an obligate glycosyl carrier 
lipid crucial for protein N-glycosylation, O-mannosylation, C-mannosylation, and GPI anchor 
synthesis (2, 6, 23). Similarly, the bacterial cis-PTase, including the most common undecaprenol 
pyrophosphate synthase (UPPS), plays an essential role in maintaining cellular integrity by 
synthesizing UPP (11 C5), a carrier lipid for N-acetylglucosamine-N-acetylmuramate 
pentapeptide moiety required for bacterial cell wall synthesis (24, 25). Therefore, UPPS serves as 
a target for the development of more effective antibiotics (24, 26-28).  
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Based on enzyme composition, cis-PTases can be either homodimeric or heteromeric 
enzymes (2, 10). The classification can be further extended to include product chain length in 
which the majority of homodimeric enzymes synthesize short-chain (2-5 C5) or medium-chain 
(9-11 C5) products whereas heteromeric enzymes tend to synthesize long-chain (14-24 C5) or 
very-long-chain (> 2,000 C5) products (2, 6). Many organisms including bacteria, some archaea, 
plants, and some protozoa such as Giardia and Trypanosoma possess a homodimeric cis-PTase 
assembly (2, 14, 29-36). Heteromeric enzymes, on the other hand, can be found in yeast, 
mammals, fungi, slime molds and some archaea and plants; these enzymes are mainly involved 
in the biosynthesis of long-chain dolichols required for dolichol-dependent protein glycosylation 
(2, 37-39). The well-known heteromeric cis-PTase synthesizing extensively long isoprenoids is 
rubber synthase (40, 41). Recently, studies on natural rubber biosynthesis have gained 
considerably increased attention from an industrial standpoint due to its unique physical 
properties and the high demand for sustainable rubber resources. Clearly, cis-PTases are diverse 
group of enzymes that synthesize wide range of precursors vital across all domains of life.  
1.3  Evidence for the heteromeric organization of eukaryotic cis-PTase 
The first eukaryotic genes encoding the putative S.cerevisiae cis-PTase proteins RER2 
and SRT1 were identified two decades ago (15, 42, 43). Overexpressing either RER2 or SRT1 
gene suppresses the phenotype of a rer2 strain defective in yeast growth, protein sorting, cis-
PTase activity and protein glycosylation (15). Subsequently, sequence homology analysis 
resulted in the identification of a cDNA encoding the human dehydrodolichyl diphosphate 
synthase (DHDDS) subunit (20, 22). Similar to RER2 and SRT1, the human DHDDS 
complements growth defects, cis-PTase activity and restores normal protein glycosylation levels 
in the rer2 mutant strain (22). Although DHDDS has no predicted trans-membrane domains, it is 
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membrane-associated (22). Furthermore, overexpression of DHDDS in mammalian cells results 
in a modest increase in cis-PTase activity from isolated microsomal fractions, indicating the 
requirement of an additional cis-PTase subunit (22). NgBR was first identified in the Sessa lab as 
a receptor that binds the amino terminus of Nogo-B (or reticulon 4B), a protein that is highly 
abundant in endothelial cells and vascular smooth muscle cells and plays an important role in 
adhesion and chemotaxis of endothelial cells (44). Initial studies on the cellular role of NgBR 
demonstrated an interaction between the C-terminus of NgBR and Niemann-Pick type C2 
(NPC2), a lysosomal protein involved in the trafficking of LDL-derived cholesterol (45, 46). In 
addition, loss of NgBR using siRNA reduced the levels of NPC2 and induced accumulation of 
free cholesterol, a phenotype similar to NPC2 loss-of-function mutations (45). Furthermore, 
NgBR knockdown cells showed a remarkable decrease in cis-PTase activity, dolichol levels and 
protein N-glycosylation, suggesting a possible role in cis-PTase enzymatic function (46). Indeed, 
amino acid sequence analysis revealed a 44% sequence similarity between the C-terminus of 
NgBR and the homodimeric cis-PTase from M.luteus (46). Furthermore, co-immunoprecipitation 
studies established an interaction between the C-terminus of NgBR and DHDDS, indicating the 
presence of a heteromeric cis-PTase complex (46).  
Genetic and biochemical studies from the Sessa group provided an unequivocal evidence 
for the heteromeric organization of cis-PTase in yeast and human. Studies in yeast demonstrated 
that a triple deletion yeast strain from S.cerevisiae lacking its three cis-PTase components, 
including NUS1 (NgBR ortholog) and RER2 and SRT1 (DHDDS orthologs) was lethal, and 
survival of yeast cells was accomplished by expressing a homodimeric cis-PTase from G.lamblia 
(refer to method section for more details) (39). Similarly, viability of the triple deletion yeast 
strain was only possible by the co-expression of both NgBR and DHDDS but not individual 
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genes. These observations were further supported by a reverse-phase TLC analysis showing 
polyprenol formation occurring only in the presence of both cis-PTase components (39). In 
addition, in vitro-translation experiment combined with cis-PTase activity assay clearly 
demonstrated that only co-translation and not mixing of the two subunits reconstituted the 
activity of the complex (39). Subsequent work by other groups further bolstered the strict 
requirement of both subunits for cis-PTase activity and polyprenol synthesis in distantly related 
species. Using yeast two-hybrid screen and co-immunoprecipitation assays, Brasher et al.(37) 
demonstrated that a heteromeric cis-PTase from tomato required SICPT3 (DHDDS ortholog) and 
SICPTBP (NgBR ortholog) to complement growth defects and dolichol deficiency of yeast 
mutant lacking RER2 gene. Similar results were reported by Epping et al. (40) whereby the 
interaction of rubber synthase components TbCPT1 (DHDDS ortholog)/TbRTA (NgBR 
ortholog) from Dandelion was confirmed by co-immunoprecipitation experiments. Moreover, 
expressing individual subunits failed to support cellular growth in the S.cerevisiae triple deletion 
strain (40). Yet in another study by Qu et al. (41), the plant cis-PTase complex from Lettuce was 
shown to consist of CPT3 (DHDDS ortholog) and CPTL2 (NgBR ortholog) using a yeast two-
hybrid screen. In addition, only yeast microsomes containing CPT3/CPTL2 showed enhanced 
synthesis of cis-polyisoprenoids (41). Similar results were reported in a study by Kwon et al. 
(47) which demonstrated the requirement of both cis-PTase subunits CPT1 (DHDDS ortholog) 
and AtLEW1 (NgBR ortholog) in A.thaliana using yeast complementation and in-vitro activity 
assays. Recently, our group successfully isolated and biochemically characterized an archaeal, 
heteromeric cis-PTase from M.acetovorans, which consists of the two subunits MA3723 
(DHDDS ortholog) and MA4402 (NgBR ortholog) (9). Similar to previous findings, both 
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subunits were necessary for the survival of the triple deletion yeast strain and optimal cis-PTase 
activity (9).  
 1.4  The molecular mechanism of heteromeric cis-PTase remains elusive 
Our current mechanistic understanding of cis-PTase enzymes stems mainly from 
structural and biochemical studies on homodimeric enzymes which have been well characterized 
two decade ago. The first crystal structure reported for this enzyme group was from M.lutues 
UPP synthase (48). Subsequent crystal structures of other homodimeric cis-PTs revealed a 
similar structural fold in which each monomer consisted of six parallel β strands and seven α 
helices (28, 49-51). The enzymatic reaction takes place within a hydrophobic cavity composed of 
two α helices and two β strands (50, 52). Comprehensive structural and functional studies 
showed that most conserved residues involved in catalysis and substrate binding are located 
within the entrance of the cavity which is surrounded by positively charged residues to bind and 
stabilize the negatively charged pyrophosphate of the two substrates and product (50, 52, 53). In 
addition, previous fluorescence studies concerning the role of Mg2+ in substrate binding revealed 
that binding of the allylic substrate (i.e. FPP) is independent of Mg2+ while IPP binding only 
occurs in complex with Mg2+(50). A highly conserved Aspartic acid (Asp26 in E.coli UPPs) 
within the active site was shown to coordinate with Mg2+ and play an important role in catalysis 
as suggested by the 1000-fold reduction in kcat upon mutation to Alanine (54). The interior side 
of the cavity is surrounded by hydrophobic residues which can participate in binding the 
hydrophobic tail of the product; such assumption was supported by a crystal structure of E.coli 
UPPs in complex with Triton which is thought to mimic UPP, the product of the bacterial 
enzyme (52).  
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In contrast, the structure and molecular mechanism of heteromeric cis-PTase remains 
elusive due to their recent discovery. Identification of several heteromeric cis-PTs from different 
organisms revealed that DHDDS-like proteins retain most cis-PTase active site residues involved 
in catalysis and substrate binding (9). Nevertheless, purified DHDDS is only slightly active on its 
own (55). NgBR and its orthologs on the other hand seem to lack most of the functionally 
conserved residues except for a conserved C-terminal -RXG- motif, shared with homodimeric 
cis-PTases but not DHDDS orthologs (9). Both NgBR and DHDDS-like proteins retain the 
canonical dimeric interface region of homodimeric cis-PTase enzymes (9). Interestingly, NgBR 
harbors an N-terminal region that can bind to the ER membrane (46). Therefore, different roles 
have been assigned to NgBR-like proteins by various groups. A docking role was reported by 
Yamashita et al. (56), who recently described a three-component rubber synthase system from 
Hevea brasiliensis consisting of HRT1 (DHDDS ortholog), HRBP (NgBR ortholog) and a 
rubber elongation factor. Moreover, it was suggested in other studies that NgBR anchoring may 
activate DHDDS (57) or facilitate product release into the membrane (58). Although most NgBR 
orthologs are membrane anchored compared to the membrane-associated pattern of DHDDS, the 
anchoring role has been challenged by the following observations: First, a knockdown of NgBR 
showed no change in the relative abundance of DHDDS associated with isolated ER membrane 
fractions (46). Second, NgBR lacking its N-terminal domain (Δ85) still supports growth of a 
yeast triple strain when co-expressed with DHDDS (9). Lastly, a recently identified NgBR 
homolog from Archaea (MaUPPS-B) lacks the N-terminal domain containing the predicted 
membrane binding region yet was able to support cis-PTase activity and protein glycosylation 
(9). It is possible that the main role of NgBR is to stabilize the heteromeric complex; however, 
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recent functional studies from our group strongly suggest its additional role in cis-PTase 
enzymatic activity through its shared C-terminal -RXG- motif (9).  
1.5  Genetic disorders associated with cis-PTase loss-of-function mutations 
In the past few years, dolichol metabolism has received a considerable interest as more 
studies emerged demonstrating a clear relationship between defects in dolichol biosynthetic 
genes and numerous human diseases. More specifically, exome sequencing of patients with 
congenital disorders of glycosylation (CDG) type I has identified number of disease-causing 
mutations in both NgBR and DHDDS subunits (39, 59-63). A homozygous mutation (R290H) at 
the C-terminal -RXG- motif of NgBR was reported in a family of Roma origin (39). Individuals 
with this mutation exhibited a severe CDG type I phenotype with multi-organ symptoms 
including congenital scoliosis, refractory epilepsy, retinitis pigmentosa, microcephaly and severe 
neurological impairment (39). Biochemical characterization of R290H mutation by our group 
showed a marked reduction in cis-PTase activity as well as IPP binding with no influence on its 
interaction with DHDDS (9, 39). These data suggest a possible role for NgBR in catalysis and 
IPP binding through its C-terminal -RXG- motif (51, 64, 65). Another two homozygous 
mutations (K42E, T206A) in DHDDS were reported in individuals with a mild form of CDG 
whereby patients suffered from a nonsyndromic, autosomal recessive Retinitis Pigmentosa, 
commonly found among the Ashkenazi Jewish population (62, 63, 66). Interestingly, patients 
harboring either the NgBRR290H or DHDDSK42E homozygous mutations showed altered ratios of 
dolichol chain length in urine and plasma (39, 66). However, the physiological significance of 
this phenotype is still poorly understood. Yet another exome sequencing study recently reported 
several de novo heterozygous mutations in NgBR/DHDDS complex associated with neurological 
abnormalities in CDG. The symptoms lead to Developmental and Epileptic Encephalopathy 
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(DEE), a group of conditions characterized by re-occurrence of epilepsy and intellectual 
disability (ID) , electroencephalographic abnormalities and in few cases, early death (60, 67). 
Individuals carrying the de novo mutations displayed various neurological symptoms typical of 
DEE including epilepsy, seizures, tremors, ataxia and moderate to severe developmental delay 
(60). Moreover, micro-deletions within NgBR locus have been associated with pediatric epilepsy 
and congenital anomalies (68, 69). Finally, a recent exome sequencing study by Guo et.al, (70) 
identified de novo mutations in NgBR which might be relevant to Parkinson’s disease 
pathogenesis, although it is uncertain whether these mutations affect cis-PTase activity.  
1.6  NgBR regulation and cancer prognosis 
In recent years, there has been a growing number of studies describing the correlation 
between NgBR expression and tumorigenesis. In the area of breast cancer research, it was shown 
that NgBR expression levels were elevated in breast cancer cells in relation to normal, non-
transformed breast cells (71-73). More specifically, NgBR protein was highly expressed in 
estrogen receptor alpha (ERα)-positive/Her2-neggative breast cancer and was positively 
correlated with the expression of survivin, a well-known apoptosis inhibitor (72). In another 
study by Zhao et al. (74), NgBR knockdown was shown to reduce epithelial-mesenchymal 
transition (EMT), an essential process involved in breast cancer metastasis. Therefore, NgBR 
may play a role in the progression and metastasis of invasive ductal breast carcinoma. Several 
lines of evidence exist demonstrating an altered pattern of protein O- and N-glycosylation in 
cancer cells compared to normal cells (71, 75, 76). Given the essential role of NgBR as part of 
cis-PTase complex required for protein glycosylation, it might be reasonable to conclude that 
NgBR upregulation in tumorigenic cells occurs in response to the increasing demand for protein 
glycosylation. Moreover, it was previously shown that NgBR can interact with farnesylated Ras 
10 
 
and promote its accumulation to the plasma membrane, a crucial step required for the activation 
of epidermal growth factor (EGF) signaling pathway in breast cancer cells (77). In addition, 
NgBR overexpression was found to promote the activation of Ras-mediated EGF signaling, and 
Akt/ERK-mediated MDM2 phosphorylation, leading to the ubiquitination and degradation of 
p53 (78, 79). Such molecular mechanism is thought to explain the chemoresistance of ERα 
positive breast cancer cells to paclitaxel and tamoxifen (78, 79). A similar NgBR-Ras activation 
effect was observed in non-small cell carcinomas (NSCLC) cells (80, 81). According to these 
studies, NgBR knockdown was shown to inhibit EMT of NSCLC cells, whereas NgBR 
overexpression promoted Ras activation and its downstream MEK/ERK/Snail1 signaling 
pathway (81). Nevertheless, more studies are needed to fully illustrate whether NgBR-mediated 
Ras activation involves cis-PTase pathway or contribute to an independent role of NgBR in 
cancer progression and metastasis.  











1.7  Thesis aims 
Dolichol plays a crucial role as a gylcosyl carrier lipid required for proper protein 
glycosylation. Nevertheless, the steps leading to its biosynthesis remain poorly characterized. 
Cis-prenyltransferase (cis-PTase) is the first enzyme committed to the de novo biosynthesis of 
dolichols in eukaryotes (15, 19, 22). Recent studies by our group and others have already 
confirmed the heteromeric organization of eukaryotic cis-PTase enzyme, which consists of 
NgBR and DHDDS subunits in humans (37, 39-41, 46). In line with the significance of protein 
glycosylation for proper cellular function, mutations in both NgBR and DHDDS subunits have 
been associated with various clinical symptoms, ranging in severity from the mild retinitis 
pigmentosa to the fatal cases of congenital disorder of glycosylation (CDG type I) (39, 59-63, 
70). Despite the growing clinical relevance of cis-PTase enzymes,  a thorough investigation of 
heteromeric cis-PTases has been lacking due to their recent discovery. Towards this end, my 
thesis sought to gain an insight into the molecular mechanism of heteromeric cis-PTases through 
a structural-functional approach.  
Thesis aim: Investigate the molecular mechanism of heteromeric cis-PTase enzymes through the 
utilization of x-ray crystallography 
To gain a mechanistic understanding of heteromeric cis-PTase enzymes, I will determine 
the atomic structure of the human NgBR/DHDDS complex using x-ray crystallography 
technique. The structure will help shed light on the molecular determinants governing: 1) the 
heteromeric assembly of the two distantly related NgBR and DHDDS subunits to form a 
functional enzymatic complex; 2) the similarities and differences between the active site of 
heteromeric and homodimeric cis-PTase enzymes; 3) the mechanism underlying NgBR and 
DHDDS-related human diseases; 4) the role of membrane binding in enzyme activation; 5) the 
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mechanism by which heteromeric cis-PTase enzymes synthesize longer-chain polyprenols 
compared to homodimeric enzymes. Therefore, the structural study proposed herein will provide 
the first biophysical evidence for the interaction between NgBR and DHDDS subunits and will 

















CHAPTER 2: The Crystal Structure of Human cis-PTase (NgBR/DHDDS) Complex 
Reveals Novel Insights into the Molecular Mechanism of Heteromeric Enzymes 
2.1  Introduction 
Until now, all studies concerning the structure and catalytic mechanism of cis-PTase have 
been limited to homodimeric enzymes. In contrast, our mechanistic understanding of prenyl 
chain elongation by heteromeric enzymes remains elusive. Previous biochemical studies from 
our lab confirmed the heteromeric organization of the human cis-PTase, which consists of NgBR 
and DHDDS subunits (39, 46). Unlike homodimeric cis-PTases which synthesize short and 
medium-chain length products (e.g., E.coli UPPS; 11 isoprene units); human cis-PTase catalyzes 
the condensation of sixteen IPP units with a single farnesyl pyrophosphate (FPP) molecule, 
generating a long-chain polyprenol diphosphate (19 isoprene units) (SI appendix, Fig. S1) (2) . 
Once synthesized, the polyprenol diphosphate is then dephosphorylated by an unknown 
phosphatase, generating polyprenol. The α-isoprene unit of the polyprenol is subsequently 
reduced by an NADPH-dependent polyprenol reductase, resulting in the formation of dolichol. 
The last step involves phosphorylating the dolichol by a dolichol kinase to form dolichol 
phosphate, the glycosyl carrier lipid required for various types of protein glycosylation in the 
lumen of endoplasmic reticulum (2, 6, 23). The essential role of cis-PTase in dolichol synthesis 
was demonstrated using yeast, mice, and zebrafish as genetic models. Notably, a global knockout 
of NgBR in mice (39) and endothelial specific knockout of NgBR (82) leads to embryonic 
lethality due to defects in vascular development. Similarly, NgBR knockdown in zebrafish 
embryos shows defects in intersomitic vessel sprouting (83). In addition, deletion of yeast 
S.cerevisiae cis-PTase components including Rer2/Srt1(DHDDS orthologs) and Nus1 (NgBR 
ortholog) fails to support growth of yeast cells (30, 39). Moreover, in vitro studies using 
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endothelial-specific NgBR knockdown cells show a marked reduction in cell proliferation and an 
increase in apoptosis, mainly due to the hypoglycosylation of essential endothelial cell proteins 
such as VEGFR2 (82).  
Several lines of evidence exist supporting the requirement of both NgBR and DHDDS 
and their orthologs for a functional cis-PTase enzyme (9, 37, 39-41, 46, 47). Nevertheless, the 
specific contribution of each subunit to the overall catalytic mechanism is unclear. Intriguingly, 
DHDDS is a soluble protein yet localizes to the ER membrane (22). Additionally, DHDDS 
shares a high sequence homology (up to 50% sequence similarity) with homodimeric cis-PTases, 
thus retaining most active site residues involved in catalysis and substrate binding (9). In 
contrast, NgBR can be divided into two domains: An N-terminal domain which exhibits a 
membrane-binding region, and a C-terminal domain that seems to share a low sequence identity 
with homodimeric cis-PTases by lacking most active site residues (9, 44). However, our group 
has recently identified a conserved -RXG- motif at the very C-terminus of NgBR; the motif is 
shared with homodimeric cis-PTases but not DHDDS and its orthologs (9). A functional analysis 
of the C-terminal -RXG- motif revealed its critical role in catalysis and binding of the IPP 
substrate (9); thus, suggesting a catalytic role for the NgBR subunit. Recently, the structure of 
cis-PTase domain of Nus1 (NgBR ortholog from yeast) was reported (84); surprisingly, Nus1 
adapts a structural fold similar to that of homodimeric cis-PTase enzymes. Additionally, 
sequence alignment studies revealed both NgBR and DHDDS to maintain the canonical interface 
region commonly found in homodimeric enzymes (9). Nevertheless, a more thorough 
investigation is needed to elucidate the dimeric interaction and the real contribution of both 
subunits to the overall molecular mechanism of heteromeric cis-PTases. Towards this end, I 
developed a bacterial system for the co-expression and purification of the human NgBR/DHDDS 
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complex. Next, I successfully co-crystallized the heteromeric enzyme in complex with Mg2+ ion 
and IPP substrate at 2.3 Å. The structural-functional analysis unveiled novel features that were 
not previously predicted based on the structures of homodimeric enzymes. These features 
include a unique C-terminal domain on DHDDS that seems to contribute to the 
heterodimerization of the complex, a novel N-terminal membrane sensor on DHDDS that is 
critical for membrane activation, and a unique structural feature within the hydrophobic cavity of  
DHDDS that plays a role in product chain elongation. In addition, the structure confirmed the 
involvement of NgBR in the overall catalytic mechanism of cis-PTase and provided a 
mechanistic insight into the loss of function mutations associated with CDG. Therefore, 
NgBR/DHDDS complex structure sheds light on different molecular aspects of heteromeric cis-













2.2  Materials and Methods 
Materials 
 Unless otherwise stated, all reagents were of analytical grade and purchased from Sigma-
Aldrich, Thermo Fisher Scientific, and Zymo Research (Irvine, CA). Restriction enzymes were 
from New England Biolabs (Ipswich, MA). [1-14C] IPP (50 mCi/mmol) was purchased from 
American Radiolabeled Chemicals (St. Luis, MO). Reverse phase thin layer chromatography 
(RP18-HTLC) plates were from MilliporeSigma (cat# 1.51161.0001). Primary antibodies used in 
this study include Anti-HA High Affinity antibody (Roche, 11867423001) and Monoclonal anti-
Flag M2 antibody (Sigma, F3165). HiFi DNA Assembly method (NEBuilder®, NEB) was used 
to construct expression vectors and perform site-directed mutagenesis.  
 
Cloning and Purification of NgBR/DHDDS Complex 
To express His-SUMO-NgBR79-293 and untagged, full length DHDDS (1-333) in bacteria, 
His-SUMO and NgBR overlapping PCR fragments were first assembled into pRSF-DUET1 
vector cut with NdeI/XhoI restriction enzymes. DHDDS PCR fragment was then assembled into 
pRSF-DUET1-HIS-SUMO-NgBR cut with NcoI/NotI. The Recombinant NgBR/DHDDS 
complex was expressed in Escherichia coli Rosetta (DE3) cells (Novagen) and induced with 0.7 
mM IPTG (OD600 0.6) overnight at 18 ⁰C. Cells were harvested and then resuspended in lysis 
buffer containing 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 20 mM imidazole, 10% glycerol, 
0.5% triton X-100 and 2 mM 2-Mercaptoethanol, cOmplete protease inhibitors (Roche), 
lysozyme (100 μg/ml) and DNase I (10 μg/ml). Three cycles of freeze/thaw were conducted 
using ethanol/dry ice bath and cells were sonicated in 50 ml falcon tube for 2 minutes total. The 
samples were clarified by centrifugation at 20,000 rpm for 1 hour at 4 ⁰C. Supernatant was then 
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applied to a 1 ml HisTrap (GE Healthcare) nickel affinity column, and the protein was eluted 
with 6 ml lysis buffer containing 400 mM imidazole. The sample was then applied to size 
exclusion column (Superdex 200, GE Healthcare) equilibrated with buffer containing (50 mM 
Tris-HCl pH 8.0, 150 mM NaCl, 1 mM MgCl2 and 2 mM TCEP). Fractions containing protein 
complex were collected and subjected to cleavage with SUMO protease overnight at 4⁰C to 
remove the His-SUMO tag. The cleaved protein was then re-applied to a HisTrap column and the 
flow-through was collected. Protein sample was then passed through another size exclusion 
column equilibrated with 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2.5 mM MgCl2 and 2 mM 
TCEP. Fractions were collected and analyzed by 12% SDS-PAGE gel.  
 
Crystallization, Data Collection and Structural Determination 
The purified protein was concentrated to 3.2 mg/ml and incubated with 3.3 mM IPP 
(sigma) on ice for 2 hours. Crystallization screening was performed using the sitting-drop vapor 
diffusion method, and an initial hit was obtained from PEG screen (Hampton Research). 
Crystallization was optimized by grid screening and the best crystals were obtained by mixing 1 
μl protein solution with 1 μl reservoir solution consisting of 0.1 M Bicine (pH 8.5), 10% v/v 2-
propanol, 22% PEG 1500. Crystals appeared within 2 days and grew to maximum size within 
one week at room temperature. Crystals were cryoprotected with the reservoir solution 
supplemented with 20% glycerol and flash frozen in liquid nitrogen. Diffraction Data were 
collected on beamline 24-ID-E of the Advanced Photon Source at Argonne National Laboratory 
and processed using HKL2000 (85). Although individual reflections up to 2.2 Å resolution could 
be observed, after merging, CC1/2 quickly fell off beyond 2.3 Å. The structure of the complex 
was determined by molecular replacement and refined to 2.3 Å resolution using CCP4i 
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(supplementary Table 1) (86). The E. coli UPPs (PDB entry 1X06) and S. cerevisiae NUS1 
(PDB entry 6JCN) were used as search probes for the DHDDS and NgBR subunits, respectively. 
Model building were performed using Coot (87).  
cis-PTase activity of NgBR/DHDDS 
The steady state activity of purified NgBR/DHDDS complex was assayed as before with 
minor modifications (9). Briefly, a standard incubation mixture contained, in a final volume of 
25 μl, 100 μM [1-14C] IPP, 20μM FPP, 50 mM Tris-HCl pH 8.0, 1 mM MgCl2, 10 mM KF, 20 
mM 2-mercaptoethanol, 1 mg/ml BSA ,1 % Phosphatidylinositol and 100 ng of purified enzyme. 
The mixture was incubated for 1 hour at 37 ⁰C and product was extracted with 
chloroform:methanol (3:2), followed by washing three times with 1/5 volume of 10 mM EDTA 
in 0.9% NaCl.  In order to determine the chain length of the cis-PTase products, polyprenol 
diphosphates were chemically dephosphorylated by incubation of the lipids at 90° in 1 N HCl for 
1 hr. Dephosphorylated prenols were extracted three times with two volumes of hexane. The 
organic fraction was washed with 1/3 volume of water, hexane was evaporated under stream of 
nitrogen and   lipids were loaded onto HPTLC RP-18 precoated plates and run in acetone 
containing 50 mM H3PO4. The plates were exposed to film to visualize the products of IPP 
incorporation. As an internal and external standards Geranylgeraniol (Echelon Biosciences), 
Undecaprenol and Polyprenol 19 (Institute of Biochemistry and Biophysics, PAS 
the Collection of Polyprenols) and Prenols mixture (13-21) (Avanti Polar Lipids) were used. 
Prenol standards were visualized by exposing the TLC plate to iodine vapor.  
 
Limited Proteolysis  
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20 ul of 0.2 mg/ml of purified NgBR/DHDDS enzyme was incubated with 5 ul of a 
protease including thermolysin (Sigma),  proteinase k (Sigma) and trypsin (Sigma) at different 
concentrations (0.005, 0.01, 0.02, 0.04, 0.08, 0.16 mg/ml). The reaction mixture was incubated at 
room temperature for 30 minutes and stopped with SDS buffer containing 5.2 mM PMSF and 5.2 
mM EDTA. Samples were boiled for 5 minutes and analyzed by12% SDS-PAGE gel. 
 
Co-Immunoprecipitation  
HEK293T cell was transfected using lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s protocol and harvested 48 hrs after transfection. Cells were collected and lysed in 
IP buffer (IP buffer: 50mM HEPES, 150mM NaCl, 1mM EDTA, 1% Triton X-100, Complete 
Protease Inhibitors (Roche)). Lysates were cleared by centrifugation at 12000 rpm for 10 min 
and 10μl of anti-Flag M2 magnetic beads (Sigma) was used to pulldown the Flag-tagged protein 
from 0.5-1 mg of cell lysate. After incubation for 2 hours at 4˚C, magnetic beads were washed 
with IP buffer, resuspended in 2X Laemmli sample buffer and boiled for 5 min before western 
blot analysis. 
 
Yeast Complementation Assay 
For yeast complementation analysis of cis-PTase, S. cerevisiae strains KG405 
(nus1Δ rer2Δ srt1Δ), carrying the Glcis-PTase encoding gene on a plasmid with a URA3 marker 
was used (39). To phenotypically analyze human cis-PTase mutants, strain KG405 was 
transformed with vectors pKG-GW1 carrying DHDDS variants (leucine selection) and pKG-
GW2 carrying NgBR variants (methionine selection) in combination or empty vectors as 
negative control. Transformed yeast cells were grown overnight at 30 °C in synthetic defined 
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medium or lacking uracil, methionine, and leucine were streaked onto synthetic defined medium 
containing all amino acids, nucleotide supplements, and 1% (w/v) 5-FOA (Zymo Research) and 
onto YPD plates. The plates were incubated for up to 5 days at 30 °C. Colonies growing on the 
5-FOA plates were streaked on synthetic defined medium lacking uracil and incubated at 30 °C 
for 3 days to verify the loss of the pNEV-Glcis-PTase plasmid. Yeast strain KG405 and its 
derivative carrying NgBR/DHDDS complex were cultured in 2% (w/v) Bacto peptone and 1% 
(w/v) yeast extract supplemented with 2% glucose (w/v) (YPD). Synthetic minimal media were 
made of 0.67% (w/v) yeast nitrogen base and 2% (w/v) supplemented with auxotrophic 
requirements. For solid medium, agar (BD Biosciences, Sparks, MD) was added at a 2% (w/v) 




To estimate the chain length of dolichols produced by EKE deletion mutant, total lipids 
from 3 g of yeast cells grown overnight till late logarithmic phase of growth (OD 3-4) were 
extracted by the modified Folch method. Lipids extracted from yeast cells were hydrolyzed in 
hydrolytic solution containing toluene/7.5% KOH/95% ethanol (20:17:3, v/v/v) for 1h at 90°C. 
Nonsaponifiable lipids were then extracted four times with hexane, purified on silica gel 60 
columns using isocratic elution with 10% diethyl ether in hexane, evaporated to dryness in a 
stream of nitrogen and dissolved in isopropanol. Extracts were analyzed by HPLC using a 
Waters dual-pump HPLC device coupled with a Waters Photodiode Array Detector (spectrum 
range: 210 - 400 nm) and ZORBAX XDB-C18 (4.6 × 75 mm, 3.5 μm) reversed-phase column 
(Agilent, USA). Polyisoprenoids were eluted using the solvent mixtures A - methanol/water, 9:1 
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(v/v) and B - methanol/isopropanol/hexane, 2:1:1 (v/v/v) combined as follows from 0% B to 
75% B in 20 min, from 75% B to 90% B in 5 min, from 90% B to 100% B in 2 min, 100% B 
maintained for 11 min, then from 100% B to 0% B in 1min at a flow rate of 1.5 mL/min. The 
chain length and identity of lipids were confirmed by comparison with external standards of a 





















2.3  Results 
2.3.1  The core catalytic domain of NgBR/DHDDS complex 
Previous SAXS analysis and circular dichroism studies by Holcomb et.al (88) showed a 
globularly folded protein when an NgBR construct devoid of its N-terminal region (1-78) was 
expressed and purified from bacterial cells. Accordingly, I co-expressed and purified a polyHis 
and SUMO-tagged NgBR (79-293) with full-length, untagged human DHDDS (1-333) using 
bacterial E.coli cells (Fig. 2.1A). The system yielded a highly pure, monodisperse protein in 
milligram quantities that are suitable for structural studies (Fig. 2.1B). Interestingly, upon careful 
examination of the size exclusion chromatogram, the protein complex seemed to elute at a 
volume that is higher than its expected molecular weight (~ 70 KDa). Further investigation using 
size-exclusion chromatography multi-angle light-scattering (SEC-MALS) revealed similar 
results, whereby the estimated molecular weight of the complex was ~ 120 KDa, corresponding 
to the size of a tetramer. Although only a dimeric form of the complex was crystallized (see 
below), it would be interesting to determine whether the higher oligomerization state of the 
protein complex observed in solution is an artifact of the purification strategy employed or has 
any physiological relevance. Next, I measured the enzymatic activity of the purified complex 
using radioactive [1-14C] IPP substrate and cold FPP at steady-state conditions. The truncated 
complex exhibited full enzymatic activity similar to that of the full-length protein complex 
previously purified from mammalian Expi 293 cells (9). Furthermore, previous work from our 
lab demonstrated the requirement of phospholipids such as phophotidylinositol (PI) to potently 
stimulate the activity of purified NgBR/DHDDS enzyme (9). Accordingly, measuring protein 
stimulation by PI showed no difference between the truncated and the full-length protein 
complex (Fig. 2.1C). These results further support the notion that the N-terminal domain of 
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NgBR, which harbors a predicted membrane-binding region, is not required for the  activity of 
the complex. Moreover, removing the N-terminal region of NgBR did not alter the range or 
relative abundance of the polyprenol pyrophosphate, the reaction product, when analyzed by 
















Figure 2.1 The catalytic core domain of human cis-PTase. 
 
(A) Comparing the domain structure of NgBR, DHDDS and E.coli UPPS. The cis-PTase domain 
is colored yellow; N- and C-terminus of NgBR and DHDDS, gray; N-terminus of E.coli UPPS, 
blue. 
(B) Purification of NgBR/DHDDS complex. Left Panel: Coomassie-stained SDS/PAGE showing 
purification steps. Lane 1: uncleaved 6HIS-SUMO-NgBR/DHDDS complex, Lane 2: cleaved 
NgBR/DHDDS complex and SUMO, Lane 3: NgBR/DHDDS complex after removing SUMO. 
Right panel, Size exclusion chromatography profile of the purified complex after cleavage with 
SUMO protease. 
(C) Stimulation of cis-PTase activity of NgBR/DHDDS complex by phosphatidylinositol (PI). The 













2.3.2  Overall structure of the heteromeric complex 
To better understand the molecular mechanism of heteromeric cis-PTases, I sought to 
determine the structure of NgBR/DHDDS complex using x-ray crystallography. The complex 
was successfully crystallized at 2.3 Å, in the presence of Mg2+ and IPP substrate using the 
sitting-drop vapor diffusion method. The crystal belongs to the space group R32, and the 
asymmetric unit contains a single NgBR/DHDDS heterodimer. The structure was determined by 
molecular replacement using E.coli UPPS (PDB entry 1X06) and S.cerevisiae Nus1 (PDB entry 
6JCN) as search probes for DHDDS and NgBR, respectively (Fig 2.2A; SI appendix, Table S1) 
(50, 84). The structure revealed many unique features that were not previously observed in the 
search probes (SI appendix, Fig. S2-6). As shown in the structure, NgBR is composed of seven 
α-helices and six β-strands compared to nine α-helices and six β-strands in the DHDDS subunit. 
The superposition of DHDDS with E.coli UPPS structure showed Cα RMSD of 1.2 Å, and 1.8 Å 
for NgBR and Nus1 structures. Interestingly, DHDDS possesses a novel N-terminal region 
(residues 1-24) consisting of α-helix (α0) and a random coil, which extends into the hydrophobic 
tunnel of DHDDS. Additionally, the C-terminal domain of DHDDS encompasses a unique pair 
of long α-helices (residues 251-333); the two helices are stabilized against each other by a salt 
bridge formed between D273 and R306 as well as several interactions with residues from both 
subunits; thus, contributing to the heteromeric interface of the complex. Similarly, NgBR 
structure revealed a novel N-terminal α-helix (residues 82-93) and a C-terminal segment 
(residues 286-293) which contains the catalytically conserved -RXG- motif. The two outermost 
β-strands (βC and βC’) previously observed in the Nus1 structure are disordered (residues 230-
244; SI appendix, Fig. S4). Strikingly, the peptide segment following the β-strands forms a new 
helix (α4, residues 179-186) and partially covers the hydrophobic cavity between α2 and α3, 
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which was once proposed to constitute the binding site for farnesylated Ras (77). Furthermore, a 
major difference exists between the architecture of the hydrophobic cavity of NgBR and other 
cis-PTases. In DHDDS as well as other UPPS structures, the two helices (α-helix 2 and 3) 
forming the hydrophobic cavity, are organized in a parallel fashion, thereby allowing for the 
chain elongation process (SI appendix, Fig. S5). In NgBR, however, α-helix 3 is much shorter, 
and directly associates with α-helix 2, leading to the collapse of the hydrophobic cavity. Such 
unique feature might account for the inability of NgBR to participate in the chain elongation 
process.  
The crystal structure supports earlier notion that both NgBR and DHDDS subunits are 
required for enzymatic stability (39, 46). The dimeric interface of the complex resembles that of 
bacterial UPPS enzymes as well as yeast Nus1homodimer, burying an average of 2,029 Å2 
surface area (SI appendix, Fig. S7) (50, 84). In addition to the canonical interface region, the C-
terminus of DHDDS wraps around the protein complex and makes additional contacts with 
NgBR, further contributing to the overall stability of the complex. This observation is in contrast 
with a recent modeling study demonstrating the DHDDS’s C-terminal domain folding outside 
the core catalytic domain (55). To assess the nature of interaction between NgBR and DHDDS 
subunits, I conducted limited proteolysis studies on the purified complex using different types of 
proteases including thermolysin, proteinase k and trypsin. Under all conditions, a common theme 
was observed whereby NgBR cleavage occurred prior to that of DHDDS, thus supporting the 
stabilizing effect between these two subunits (Fig 2.2B; SI appendix, Fig. S8). To further test the 
heteromeric interface, co-immunoprecipitation experiments were conducted in HEK293T cells 
expressing the protein complex with several point mutations at the interface region. As shown in 
Fig 2.2C (and in SI appendix, Fig. S9), most of these mutations weakened binding between 
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NgBR and DHDDS, owing to their essential role in maintaining the integrity of the complex. 
Given the unique architecture of DHDDS’s C-terminal region observed in the structure, I sought 
to investigate the contribution of this region using a genetic approach. Briefly, a triple deletion 
yeast strain devoid from its cis-PTase components (rer2Δ, srt1Δ, nus1Δ) and expressing a 
homodimeric cis-PTase from G.lamblia (39) was transformed with a complex containing 
different DHDDS modification and evaluated for phenotypic growth. These modifications 
included two DHDDS truncations (Δ256, Δ289) where part of α7 and the entire α8 helix were 
deleted, and a triple mutant (R306A/F313A/L317A), predicted to disrupt packing of the two C-
terminal helices based on the structure (SI appendix, Fig. S3B). Both deletion mutants failed to 
support growth of yeast cells, whereas the triple mutant delayed growth (Fig 2.2D). Therefore, 
these data further support the essential role of DHDDS’s C-terminal region and roles out the 















Figure 2.2 The overall structure of NgBR/DHDDS heterodimer. 
 
(A) Ribbon diagrams showing the front and back of the heteromeric complex. NgBR is colored in 
orange and DHDDS is colored in deep teal. Mg2+ ion is shown as a gray sphere, IPP molecules 
occupying S1 and S2 sites are shown in red and green, respectively. 
(B) Limited proteolysis of the core domain was performed by incubating the protein with 
increasing amounts of thermolysin (0.005, 0.01, 0.02, 0.04, 0.08, 0.16 mg/ml). Untreated  
protein sample is denoted as (U). In this gel, thermolysin co-migrates with the full-length DHDDS. 
(C) Co-immunoprecipitation of NgBR/DHDDS mutations introduced at the complex interface. 
HEK293T cells were co-transfected with NgBR-HA and Flag-DHDDS cDNAs; cells were  
lysed 48 hours post-transfection and immunoprecipitation performed using anti-flag magnetic 
beads. The lysate was analyzed by western blotting. 
(D) Characterization of cis-PTase mutants in the C-terminal region of DHDDS using yeast 
complementation assay. The nus1Δ rer2Δ srt1Δ deletion strain expressing G. lamblia cis-PTase 
from URA3 plasmid was co-transformed with MET15 bearing wildtype (WT) NgBR and the LEU2 
plasmid bearing either WT or mutant variants of DHDDS at the C-terminus. Three variants were 
analyzed including a triple mutation (3A) corresponding to R306A, F313, L317 and two DHDDS 
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truncation Δ256 and Δ289. The cells were streaked onto complete plates (YPD) or synthetic 
complete medium containing 1% FOA. The Ura3 protein, which is expressed from the URA3 
marker converts FOA to toxic 5-fluorouracil, forcing the cells to lose the G. lamblia cis-PTase 





















2.3.3  The active site of NgBR/DHDDS complex 
Unlike homodimeric cis-PTases which possess two active sites, one per monomer (48-
51), heteromeric cis-PTase contains one active site, mainly located on the DHDDS subunit. As 
mentioned earlier, DHDDS harbors most critical residues involved in catalysis including the 
strictly conserved Asp acid (Asp 34 in DHDDS) as well as those required for binding of the 
allylic (i.e. FPP) and homoallylic (IPP) substrates, therefore resembling the active site of a 
homodimeric enzyme. Although the overall structural fold of NgBR, and its yeast homolog 
Nus1, is similar to that of DHDDS and members of the homodimeric cis-PTase family, they lack 
main catalytic residues and are unable to catalyze the reaction due to their distorted “active site”. 
However, our recent sequence alignment studies revealed the presence of a conserved -RXG- 
motif at the C-terminus of NgBR and homodimeric cis-PTases but not DHDDS and its orthologs 
(9). Moreover, kinetic studies on the purified WT and -RXG- motif mutants showed a clear 
effect on catalysis and substrate binding. Specifically, a functional analysis of R290H, a disease 
mutation associated with fetal CDG type I case, showed ~ 4-fold reduction in kcat and up to 2-
fold increase in Km for IPP (9). Additionally, substituting G292 with Ala reduced the enzymatic 
activity to a greater extent with kcat that is 10-fold lower than that of WT enzyme and Km for IPP 
that is 5-fold higher (9). Collectively, these results strongly support a functional role of NgBR in 
the overall catalytic mechanism.  
The previously reported crystal structure of Nus1homodimer could not resolve the C-
terminal -RXG- motif region (84). In contrast, our refined structure shows clear electron 
densities, allowing us to model the entire C-terminal region of NgBR, along with two IPP 
molecules: IPP1 molecule occupying the allylic substrate binding site S1, and IPP2 occupying 
the homoallylic binding site S2, as well as a bridging Mg2+ ion (Fig 2.3A; SI appendix, Fig. S2B, 
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S6 and S10). Strikingly, the C-terminus of NgBR traverses the dimeric interface which allows 
for the complementation of the active site (Fig 2.3B). As shown in the structure, the C-terminus 
makes number of unique interactions with the IPP substrate as well as residues from DHDDS 
subunit. The main chain amide group of Leu-291 and Gly-292 of the -RXG- motif forms 
hydrogen bonds with the β-phosphate group of the homoallylic IPP substrate, while the side 
chain of Arg-290 mainly interacts with a water molecule that coordinates with the Mg2+ ion. The 
presence of a Gly within the -RXG- motif is essential by allowing this peptide to make a tight 
turn over IPP2 and further stabilizes the turn through a Hydrogen bond formed with the 
conserved Arg-85 of DHDDS, which is involved in coordination with the pyrophosphate moiety 
of the allylic substrate. Therefore, the structure provides a mechanistic insight into the molecular 
role of the conserved -RXG- motif in conjunction with our previous functional studies.  
Notably, the architecture of the allylic S1 binding site is highly conserved within the cis-
PTase family (SI appendix, Fig. S11). Although the electron density corresponding to the 
hydrophobic tail of IPP1 was weak, we were confident in our modeling strategy employed 
whereby the prenyl tail extends into the hydrophobic tunnel to accommodate the elongated 
product (Fig 2.3A). In contrast to the S1 site, comparing S2 site of many crystal structures 
revealed some discrepancies, mainly concerning the arrangement of the C-terminal -RXG- motif 
(SI appendix, Fig. S12). In most cases, structures with a disordered -RXG- motif had poorer 
occupancy of the S2 site or misplaced pyrophosphate groups. In contrast, the S2 site in our 
current structure was occupied with the homoallylic IPP2 molecule and we were able to model it 
with great certainty. As shown in the structure, the pyrophosphate group of IPP2 is stabilized by 
number of interactions with DHDDS residues including the 3 highly conserved Arg residues 
(Arg-85, Arg-205, Arg-211), and a conserved Ser (Ser-213). The S2 site is sealed by the 
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extended -RXG- motif from NgBR, which makes additional contacts with the pyrophosphate 
moiety of IPP2 substrate. The S1 and S2 sites are bridged by the catalytically important Mg2+ ion 
required for hydrolysis of the allylic pyrophosphate group (50). The Mg2+ ion is coordinated by 
the pyrophosphate moieties of the two substrates, the strictly conserved Aspartic acid (Asp-34 in 
DHDDS) and two water molecules. Finally, previous work on homodimeric cis-PTases 
demonstrated the requirement of a base, most likely an Asparagine residue (Asn-74 in E.coli 
UPPS) to abstract a proton from C2 of IPP upon forming the new double bond (50, 89). 
Similarly, our structure shows Asn-82 in DHDDS subunit positioned within close proximity to 
C2 of IPP, thus serving the same proposed role during catalysis. Clearly, the structural 
similarities described above further suggest a common catalytic mechanism shared between 















Figure 2.3 The active site of the NgBR/DHDDS complex. 
(A) Omit difference map, countered at 3.0 σ level, showing the two IPP molecules and Mg2+ ion 
bound at the active site. IPP1 is assigned to IPP molecule bound at S1 site, and IPP2 to that at S2 
site. The oxygen atoms are colored red and phosphorus atoms are colored orange. The carbon 
atoms of IPP1 are colored salmon and those of IPP2 are in green. 
(B) Detailed view of the -RXG- motif and the active site. The carbon atoms of NgBR -RXG- motif 
residues are colored orange and labeled, and those for DHDDS are colored cyan. Nitrogen atoms 
are colored blue and oxygen atoms are colored red. IPP1 and IPP2 are colored red and green, 
respectively. Mg2+ is shown as a gray sphere, and its co-ordination is indicated by the dashed lines. 
A coordinating water molecule is shown as red sphere.  
(C) The K42E retinitis pigmentosa mutation in DHDDS. A cartoon representation indicating the 
locations of Lys-42 and Glu-234 relative to the P-loop and bound substrates. DHDDS is colored 







2.3.4  Mapping disease mutations associated with the active site of NgBR/DHDDS complex 
Mutations on both NgBR and DHDDS subunits have been linked to various clinical 
phenotypes, yet the molecular mechanism underlying their pathogenicity remains unclear. 
Therefore, our solved structure provides the first mechanistic insight into these mutations. 
Notably, the majority of CDG-causing mutations cluster around the active site of the complex 
and are directly involved in catalysis and substrate binding (SI appendix, Fig. S13A). 
Specifically, DHDDS mutations R37H and R38H associated with DEE are localized within the 
S1 site; the two Arg residues make direct contact with the pyrophosphate moiety of IPP1 or the 
allylic substrate. Similarly, another DEE mutation, R211Q, localizes within the S2 site and is 
directly involved in binding the pyrophosphate group of IPP2 or the homoallylic substrate. 
Finally, the NgBR R290H mutation associated with severe CDG phenotype, is localized within 
the -RXG- motif whereby R290 makes direct interaction with a water molecule which 
coordinates with Mg2+ ion. In addition to the above mutations, the structure also allowed for a 
detailed analysis of the two mutations associated with retinitis pigmentosa, namely T206A and 
K4E2, located on the DHDDS subunit. Although uncharacterized biochemically, T206A could 
directly perturb the active site since the Thr hydroxyl group is involved in hydrogen bonding 
with the backbone amide and carbonyl of the highly conserved, and catalytically essential Asp-
34 (SI appendix, Fig. S13B, (65)). Unlike T206A, the homozygous K42E mutation, which 
affects ~ 17 % of Ashkenazi Jewish patients diagnosed with autosomal recessive retinitis 
pigmentosa (63, 90), does not directly interact with the substrate or active site residues. Previous 
predictions on the structural role of K42 residue were misleading since they were based on the 
crystal structure of UPPS enzymes. For instance, in the E.coli UPPS structure, K34, 
corresponding to K42 in DHDDS, is exposed to solvent and does not interact with any other 
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residue that could explain the mutation pathogenicity. However, our refined structure revealed a 
salt bridge formed between K42 and a highly conserved E234 (Fig 2.3C); this interaction is 
equivalent to that between W31 and D223 in E.coli UPPS. Therefore, K42E mutation will result 
in a repulsive effect that could perturb the short helix (α1) containing K42 residue. Since this 
helical region along with the proceeding P-loop are involved in FPP binding, this analysis further 
supports previous functional studies on K42E mutation which showed a reduction in Kcat and an 
increase in Km for FPP but not IPP substrate (9).  
In addition to the published mutations described above, our structure enabled for the 
characterization of series of de novo mutations on the DHDDS subunit, recently discovered by 
our collaborator Dr. Serena Galosi at Sapienza University of Rome. The mutations include: 
G35E, R37C, P233R, I135T, R205Q and S213N.These heterozygous mutations were identified 
by exome-sequencing of 20 patients suffering from various neurological  abnormalities such as: 
developmental delay; generalized tremor; epilepsy; myoclonic seizures; ataxia; mild to severe 
intellectual disability; parkinsonism; hallucinations and anxiety. Mapping these mutations on the 
structure revealed that the majority cluster around the active site of NgBR/DHDDS complex and 
are involved in substrate binding (SI appendix, Fig. S14A). The β-phosphate group of FPP 
substrate is hydrogen-bonded to the backbone amide of Gly35, which is localized on the P-loop, 
well established to be involved in FPP binding. Therefore, replacing Gly with Glu would result 
in steric clashes with nearby residues and hence perturb packing of the P-loop and might even 
disrupt the conformation of Arg38 on the proceeding α1 helix, which is also involved in FPP 
binding. In addition, the side chain of Arg37 is stabilized by a network of salt bridges with the β-
phosphate group of FPP, Glu89 on DHDDS and the main chain carboxylate group of Lys293 on 
the C-terminus of NgBR. Therefore, introducing an uncharged residue like cysteine at this 
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position could abolish the salt bridges with the β-phosphate group of FPP as well as the C-
terminus of NgBR (SI appendix, Fig. S14B). Similarly, the side chain of Arg205 forms salt 
bridges with the pyrophosphate group of IPP and replacement of Arg residue with Gln would 
eliminate these binding interactions (SI appendix, Fig. S14C). Although replacing Ser with Asn 
at position 213 can still maintain hydrogen bonding with the β-phosphate group of IPP, 
introducing a bulky side chain at this region would result in steric clashes with nearby residues, 
hence leading to a structural destabilization. While all residues mentioned above are directly 
involved in substrate binding, Pro233 and I135 are exception to this pattern. Pro233 is localized 
within a loop that connects βF with α7 and is involved in hydrophobic packing against Tyr39 on 
α1, which is involved in FPP binding (SI appendix, Fig. S14D). Therefore, replacing Pro with a 
charged residue like Arg would disrupt packing of α1 helix and hence binding to FPP substrate. 
I135 on the other hand is localized within α4 helix distal to the active site and it is unclear how a 











2.3.5  NgBR mutations and Parkinson’s disease 
A recent exome-sequencing study by Guo, et.al (70) has identified number of mutations 
on the NUS1 gene that were shown to contribute to the etiology of Parkinson’s disease. Most of 
the reported mutations (11 out of 15) occur within cis-PTase core domain of NgBR which is well 
resolved in our current structure (Fig 2.4A). Intriguingly, mapping these mutations onto the 
structure clearly revealed a scattered pattern that does not seem to affect dimerization or 
substrate binding. Next, I sought to measure the solvent accessible surface area of individual 
mutation residues to see if any pattern could emerge that may account for their pathogenicity. 
Again, no underlying pattern was observed as most residues (7 out of 11) were exposed to 
solvent (Fig 2.4D). Therefore, it is still unclear whether these mutations affect cis-PTase activity 
in vivo, or impact some other mechanism involving NgBR that is not related to dolichol 
synthesis.  
A more careful examination of the structural role played by PD mutations revealed that 
G91C could indirectly affect cis-PTase activity through the C-terminal -RXG- motif. Notably, 
Gly-91 is located on the NgBR N-terminal helix (α1) (highlighted in green, Fig 2.4A) and is 
close to lys-96, present at the end of the helix. The lys residue in turn, is involved in a network of 
hydrogen bonding with the backbone carbonyl of Tyr-284 and the side chain of Gln-289, thus 
stabilizing the -RXG- motif (Fig 2.4B). Given the critical position of Gly-91 in mediating 
contacts between helix α1 and the rest of the protein, replacement with Cys can be disruptive to 
the structure since it will interfere with the helical packing as well as interactions with the C-
terminal -RXG- motif through Lys-96. To further investigate the proposed role of Gly-91, I 
expressed and purified NgBRG91C/DHDDS mutant using the same expression/purification system 
employed for crystalizing studies . Next, I measured the steady-state activity of the WT and the 
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mutant in the presence of phosphatidylinositol. In agreement with its predicted role, G91C 
exhibited ~ 40% reduction in enzymatic activity compared to the WT enzyme (Fig 2.4C). These 
data are in line with previous observation that a splice variant of NgBR reducing its mRNA 
levels by 50% also increases PD risk (70). Furthermore, the loss of NUS1 gene in Drosophila 
reduced it climbing ability, dopamine levels, and number of dopaminergic neurons (70). 
Interestingly, dolichol accounts for ~ 14% of the dry weight of neuromelanin, a dark pigment 
presents at high concentration in dopaminergic neurons of the human substantia nigra (SN) (91, 
92), and a massive degeneration of the SN is considered one of the hallmarks of Parkinson’s 
disease. Nevertheless, further studies are needed to determine whether low dolichol levels can 
impact the normal glycosylation of certain proteins or may affect other functions that is 
independent of protein glycosylation. In summary, our structural and biochemical studies 














Figure 2.4 Missense NgBR mutations associated with Parkinson’s disease. 
 
(A) NgBR mutations related to Parkinson’s disease are shown as purple spheres and labeled. 
DHDDS is colored in gray and NgBR is colored in orange except for the N-terminal helix (α1) 
which is shown in green.  
(B) Detailed view showing the location of G91C disease mutant within NgBR colored orange 
except for α1 helix, shown in green. Gly-91 is involved in hydrophobic packing against Val-127. 
Lys-96 forms hydrogen bonds with Tyr-248 and Gln-289, which stabilize the C-terminal -RXG- 
motif.  
(C) cis-PTase activity was measured using purified wildtype and NgBR disease mutant, G91C. 
The mutant exhibits ~ 40% reduction in cis-PTase activity compared to  
wildtype enzyme. The values are the mean ±S.D. of three independent measurements. 
(D) The majority of the mutated residues is solvent-exposed. The solvent accessible surface area 








2.3.6  Regulation of cis-PTase activity by membrane binding 
Unlike the soluble UPPS enzymes, heteromeric cis-PTases are commonly found to be 
associated with a hydrophobic platform such as membrane bilayers, lipid droplets and rubber 
particles (46, 93, 94). The very N-terminus of NgBR (residues 1-56, not included in the 
structure) harbors two hydrophobic segments predicted to bind to the ER membrane. In addition, 
our refined structure revealed a unique N-terminal segment within the DHDDS subunit that is 
absent in the bacterial UPPS enzymes. The N-terminal region consists of a random coil (residues 
1-10) and a short α-helix (α0; residues 11-21). Intriguingly, the coil exhibits a unique 
conformation whereby its bulky Trp (W3) extends into the hydrophobic tunnel between the two 
helices, α2 and α3 (Fig 2.5A, left panel; Fig 2.5B); such conformation would be inadequate for 
product chain elongation during catalysis. Therefore, we hypothesize that a conformational 
change displacing the coil from the hydrophobic tunnel is essential for proper chain elongation 
(Fig 2.5A, right panel). A more detailed analysis of the short α0 helix revealed the presence of 
three hydrophobic residues (Trp-12,Phe-15, Ile-19) that are exposed to solvent. Furthermore, a 
sequence alignment analysis confirmed the conservation of this hydrophobic patch among 
DHDDS orthologs, suggesting a possible conserved role for α0 helix in membrane binding (Fig 
2.5C). In order to determine the functional consequences of such hydrophobic conservation, I 
expressed and purified a triple DHDDS mutant, whereby all three hydrophobic residues were 
substituted with Ala (W12A/F15A/I19A). The mutant displayed similar basal activity as the WT 
enzyme in the absence of phosphatidylinositol. However, the mutant was no longer potently 
stimulated with phosphatidylinositol (Fig 2.5D). Moreover, a TLC analysis of the reaction 
product revealed a difference in the length of the polyprenol formed by the triple mutant 
compared to WT enzyme. Instead of the dominant 19 isoprene units seen with the WT enzyme, 
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polyprenols as long as 22 isoprene units were formed as the dominant product by the triple 
mutant (Fig 2.5E). Taken together, we hypothesize that in addition to NgBR, DHDDS plays an 
essential role in membrane binding and activation through its N-terminal α0-helix, which acts as 
a membrane sensor. The binding is transient but sufficient to trigger a conformational change 
characterized by the displacement of the N-terminal coil; thereby unblocking the hydrophobic 


























































Figure 2.5 DHDDS’s helix 0 functions as a membrane sensor. 
 
(A) A cartoon representation of DHDDS subunit colored in deep teal. The hydrophobic cavities of 
DHDDS before (left) and after (right) N-terminal loop deletion (residues 1-10) are shown in 
yellow. The N-terminal loop and 0 helix are shown in red; the side chains of the three exposed 
hydrophobic residues are shown and labeled. The hydrophobic cavity was generated using the 3V 
web server (95).  
(B) A cartoon representation of E.coli UPPs (PDB entry 1X06) monomer colored in purple. The 
hydrophobic cavity is shown in yellow. Leu-137 involved in chain length control in UPPS is 
located at the end of the cavity.  
(C) Sequence alignment showing the conservation of three hydrophobic amino acids at the N-
terminal helix 0 among DHDDS orthologs (highlighted in red). Conserved residues are  
highlighted in yellow. Proteins represented in this alignment are orthologs of human DHDDS cis-
PTase subunit as follows: hDHDDS (human, UniProtKB  Q86SQ9-1), XlDhdds (Xenopus 
laevis;  UniProtKB Q7ZYJ5), DrDhdds ( Danio rerio, UniProtKB Q6NXA2),  CeDHDDS 
(Caenorhabditis elegans, UniProtKB Q5FC21), ScRer2 (Saccharomyces cerevisiae, UniProtKB 
P35196), ScSrt1 (Saccharomyces cerevisiae, UniProtKB  Q03175), SpRer2 
(Schizosaccharomyces pombe, UniProtKB O14171), TrRER2 (Trichoderma reesei, UniProtKB - 
G0ZKV6), AfRer2 (Aspergillus fumigatus UniProtKB - Q4WQ28 ), SlCPT3 (Solanum 
lycopersicum, UniProtKB K7WCI9), AtCPT3 (Arabidopsis thaliana, UniProtKB Q8S2T1), 





(D) Phospholipid stimulation of wildtype and W12A/F15A/I19A triple mutant is shown. 
Stimulation was compared by measuring cis-PTase activity of purified wildtype and DHDDS triple 
mutant in the presence and absence of 1% phosphatidylinositol (PI). The values are the mean ±S.D. 
of five to eight independent measurements. 
(E) Reverse phase TLC separation of dephosphorylated products from cis-PTase activity of WT 
and DHDDS triple mutation (W12A/F15A/I19A) denoted as MUT. Numbers correspond to the 
dominant polyprenols in each sample are shown at the bottom of the plate. The position of the 


















2.3.7  The mechanism of product chain elongation  
While homodimeric cis-PTases generate a product with distinct chain length, heteromeric 
enzymes have the incredible ability of generating longer chain polyprenols characterized by a 
distribution pattern. As shown in Fig 2.5E, the human NgBR/DHDDS complex synthesizes C95 
polyprenol as the dominant product, along with varying amounts of other polyprenols that differ 
by one isoprene unit. The current model of product chain elongation by cis-PTases is based on 
number of structural and biochemical studies performed on homodimeric UPPS enzymes (6, 50, 
96, 97). According to these studies, the volume of the hydrophobic tunnel correlates well with 
the size of the synthesized product. However, our structural analysis of the NgBR/DHDDS 
complex suggests that this might not be the case for heteromeric enzymes. After manually 
removing the N-terminal coil which occludes the hydrophobic tunnel (Fig 2.5A), I used 3V 
server (95) to calculate the volume of the tunnel which turned out to be around 1,300 Å3. This 
volume is similar to that of E.coli UPPS (1,200 Å3) which synthesizes medium chain C55 
products (Fig 2.5B). Therefore, to accommodate longer-chain products, two scenarios are 
possible: the first involves a conformational change that would greatly expand the hydrophobic 
tunnel, and the second involves pushing the polyprenol chain out of the tunnel. In an attempt to 
rationalize the first model, we carefully examined the structure of the human complex to look for 
obvious differences that would allow for the synthesis of longer-chain products. Intriguingly, we 
were able to identify a stretch of 3 amino acids (Glu-107, lys-108, Glu-109) located at the middle 
of α3-helix of DHDDS. Multiple sequence alignment of other eukaryotic cis-PTases revealed the 
presence of a similar insertion on DHDDS orthologs, consisting of three to five amino acids (Fig 
2.6A). Although the presence of three extra residues creates a kink or a bulge in the α3 helix of 
DHDDS, based on our computational measurements, the insert does not seem to influence the 
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volume of the hydrophobic tunnel (Fig 2.5A; left panel and Fig 2.6C). To test whether the insert 
may contribute to the synthesis of longer-chain products, a construct harboring ΔEKE deletion 
on the DHDDS subunit was generated and transformed into the yeast triple deletion strain 
(rer2Δ, srt1Δ, nus1Δ) along with WT NgBR. HPLC analysis of the total lipids isolated from 
yeast cells revealed that the ΔEKE deletion strain synthesized shorter products (dominant: Dol-
17 (C85)) compared to Dol-20 (C100) generated by the WT enzyme (Fig 2.6B). Theoretically, 
deleting the insert within DHDDS would make the tunnel similar to that of UPPS enzymes. 
Nevertheless, the length of polyprenols generated by the mutant remained > C55. Furthermore, a 
product distribution pattern can still be observed. Taken together, these data suggest that the 
EKE insert at the α3 helix might not necessarily account for the longer chain product phenomena 
observed in heteromeric enzymes. Therefore, further structural studies involving a co-crystal 
with the reaction product are needed to better understand conformational changes taking place 
during chain elongation. Interestingly, a previous crystal structure of E.coli UPPS in complex 
with Triton X-100, a molecule that may mimic the reaction product, revealed a conformational 
change involving an upward movement of the α3-helix became less kinked  compared to the 
substrate-bounded form (52). Although this conformation has the potential to increase the size of 
the hydrophobic tunnel, the protein is unlikely to be in this state during product chain elongation 
process. This is true since a large movement of the α3-helix will misplace its N-terminal region, 
which is involved in binding the pyrophosphate moiety of the allylic substrate, hence interfering 
with subsequent elongation steps. Accordingly, the second model where part of the polyprenol 
chain exits the hydrophobic tunnel seems more plausible. In a previous mutagenesis experiment 
on the E.coli UPPS, Ko et al. (98) reported that replacement of L137, located at the bottom of the 
tunnel with Ala resulted in the formation of a range of products with C75 as the major product in 
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the absence of a detergent (Fig 2.5B). These data suggest that L137, equivalent to C148 in 
DHDDS, functions as the floor of the tunnel that could block further product elongation.  
A schematic diagram illustrating the second plausible model for the chain elongation 
process within the hydrophobic tunnel of DHDDS is shown in Fig 2.6D. According to this 
model, the polyprenol chain will continue to grow inside the tunnel until reaching ~ C65 or 13 
isoprene units (tunnel volume ~1300 Å3; each isoprene unit occupies ~ 100 Å3), after which the 
product exits the tunnel and becomes exposed to solvent, where it can grow indefinitely. Such 
model is in contrast with short and medium-chain homodimeric cis-PTase enzymes, in which the 
chain-elongation process is solely taking place inside the tunnel, hence is restricted by the size of 
the tunnel. If the product continues to grow beyond the walls of the tunnel, then it might be 
reasonable to assume that the stability of the enzyme: product complex will have a great impact 
on product size. Therefore, any interaction between the exposed portion of the hydrophobic 
polyprenol and its surrounding environment, including a detergent micelle, a membrane bilayer 
or a lipid droplet can be energetically unfavorable and will disrupt the enzyme: product complex, 
leading to product release. Indeed, previous studies on E.coli UPPS showed that L137A mutant 
failed to produce long-chain products in the presence of Triton X-100 (98). Similarly, purified 
NgBR/DHDDS complex tends to form shorter chain polyprenols in the presence of 
phospholipids and vice versa. Regarding the role of EKE insert within α3 helix, we hypothesize 
that it may stabilize the enzyme: product complex, perhaps by allowing a greater conformational 
flexibility to α3 helix and its surrounding region. In summary, our proposed model provides a 
plausible explanation for the synthesis of long-chain products. Additionally, the model attributes 
the changes in the environment surrounding the enzyme: product complex to the observed 












Figure 2.6 Mechanism of chain elongation by heteromeric cis-PTases 
 
(A) Multiple amino acid sequence alignment comparing α3 helix between DHDDS orthologs and 
homodimeric cis-PTases. Highly conserved residues are highlighted in red and less conserved ones 
are shown in yellow. Region corresponding to DHDDS EKE insert is highlighted in blue; the 
region is missing in homodimeric enzymes and a gap is present instead. Proteins represented in 
this alignment are: single subunit cis-PTs: EcUPPS (Escherichia coli, UniProtKB P60472), 
MlDPPS (Micrococcus luteus, UniProtKB O82827), SaUPPS (Sulfolobus acidocaldarius, 
UniProtKB Q9HH76). Orthologues of human DHDDS cis-PTase subunit: hDHDDS (human, 
UniProtKB  Q86SQ9-1), XlDhdds (Xenopus laevis,  UniProtKB Q7ZYJ5), DrDhdds ( Danio 
rerio, UniProtKB Q6NXA2), CeDHDDS (Caenorhabditis elegans, UniProtKB Q5FC21), ScRer2 
(Saccharomyces cerevisiae, UniProtKB P35196), SpRer2 (Schizosaccharomyces pombe, 
UniProtKB O14171), SlCPT3 (Solanum lycopersicum, UniProtKB K7WCI9), AtCPT3 
(Arabidopsis thaliana, UniProtKB Q8S2T1), AtCPT4 (Arabidopsis thaliana, UniProtKB 
Q8LAR7), AtCPT5 (Arabidopsis thaliana, UniProtKB Q8LED0)  
(B) HPLC analysis of chain length of dolichol generated by WT and ΔEKE DHDDS mutant in 
yeast cells. The dolichol peaks were identified and labeled on top of the chromatogram. The WT 
cells yielded the main compound Dol-20 compared to Dol-17 in ΔEKE mutant. The chain length 
and identity of lipids were confirmed by comparison with external standards of a polyprenol (Pren-
10 – Pren-24) and dolichol (Dol-17 – Dol-23) mixtures.  
(C) Structural comparison between E. coli UPPS (PDB ID 1X06) monomer and human DHDDS 
subunit. The EKE insert within α3 helix of DHDDS creates a bigger bulge that may contribute to 




(D) Schematic diagram illustrating the proposed chain elongation mechanism for cis-PTases. Red 
arrow indicates the direction of product elongation. Exposed hydrophobic isoprene units may 
increasingly destabilize the enzyme:product complex by interacting with detergent micells (blue) 




















2.4  Discussion and Future Direction 
Here, I show the first crystal structure of NgBR/DHDDS complex solved at 2.3 Å, which  
provides novel insights into the molecular mechanism of heteromeric cis-PTase enzymes. The 
structure reveals the heteromeric assembly of NgBR and DHDDS, mainly through a canonical 
cis-PTase interface region but also partially by a newly identified C-terminal region on the 
DHDDS subunit. In addition, the structure confirms NgBR role in the overall catalytic 
mechanism through its C-terminal -RXG- motif, which completes the active side to participate in 
catalysis and substrate binding. Furthermore, the newly identified N-terminal domain on 
DHDDS plays a key role in enzyme activation by membrane binding. Our studies also provide a 
plausible mechanism for product chain elongation by heteromeric enzymes that rationalize the 
length and distribution of the synthesized polyprenols. Finally, the structure provides a detailed 
analysis of various loss-of-function mutations associated with human diseases. Collectively, 
these results advance our current understanding of the dolichol biosynthesis pathway necessary 
for protein glycosylation.  
Shortly after the publication of our structural work presented herein, another research 
group independently demonstrated the successful crystallization of the human NgBR/DHDDS 
enzyme in complex with FPP and Mg2+ ion (99). The study revealed similar heteromeric 
assembly of the two subunits and further confirmed the unique architecture of DHDDS’s N-, and 
C-terminal regions observed in our structure. Additionally, similar to our findings, NgBR C-
terminal -RXG- motif traversed the dimeric interface to complete the active side of the DHDDS 
subunit and participate in substrate binding.  
The overall structural fold of the heteromeric NgBR/DHDDS complex resembles that of 
all known homodimeric cis-PTases, whereby each subunit consists of a β-sheet core surrounded 
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by α helices. Moreover, the heteromeric complex seems to maintain the canonical interface 
region commonly found in homomeric enzymes. To further support the heteromeric assembly of 
the two subunits, DHDDS evolved a unique C-terminal region, which adopts a “helix-turn-helix” 
organization. Sequence alignment analysis of multiple DHDDS orthologs revealed a poor 
conservation of their C-terminus domain. Therefore, the functional role of DHDDS’s C-terminus 
can only be deduced via structural studies. Our refined structure demonstrates the C-terminal 
helices of DHDDS to form multiple binding interactions with NgBR and within DHDDS, thus 
creating an additional interface that provides extra support for the heteromeric complex. This 
notion was further confirmed by our yeast complementation data, which clearly show the 
essential role of this region in maintaining the integrity of the protein complex.  
The structural similarity between the active site of NgBR/DHDDS complex and 
homodimeric cis-PTases suggest a conserved catalytic mechanism among this family of 
enzymes. The pyrophosphate group of the allylic and homoallylic substrates is stabilized by a 
network of interactions with several polar residues located at the entry of S1 and S2 sites, 
respectively. The prenyl tail of the substrates extends into a tunnel lined with multiple 
hydrophobic residues to bind and stabilize the allylic substrate and reaction intermediate during 
catalysis. A Mg2+ ion is coordinated by the catalytically conserved Asp-34, the pyrophosphate 
moiety of both substrates and three water molecules. In addition to these shared features, our 
data presented here provide the first structural evidence for the involvement of NgBR in the 
overall catalytic mechanism through its C-terminal -RXG- motif.  Consistent with this notion, 
mutations on the C-terminal -RXG- motif were previously shown to reduce the catalytic activity 
and IPP binding (9). Therefore, despite the low sequence similarity with cis-PTase, NgBR 
remarkably maintains a key structural feature shared with homodimeric enzymes, which serves 
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the same function. In addition, our current structure further corrects previous assumptions which 
limited the role of NgBR to stabilization of the heteromeric complex.  
Based on structural comparisons with short and medium-chain cis-PTases, long-chain, 
heteromeric cis-PTase enzymes were predicted to exhibit a large hydrophobic tunnel to 
accommodate the long-chain product. However, our refined structure and computational 
measurements clearly suggest that this might not be the case due to the similarity in the tunnel 
volume of DHDDS and that of medium-chain E.coli UPPS (1,300 for DHDDS vs. 1,200 for 
E.coli UPPS). Furthermore, deletion of the EKE insert at the α3 helix on DHDDS still produced 
a polyprenol that is > C55 as the dominant product along with additional polyprenols that differed 
by one isoprene unit, thus retaining the two key product features that are unique to heteromeric 
enzymes. Given these observations, we propose a plausible model for the mechanism of chain 
elongation by the long-chain NgBR/DHDDS protein complex (SI appendix, Fig.S15). The 
process starts with the binding of an allylic substrate (i.e. FPP) to the S1 site, followed by IPP-
Mg2+ complex at the S2 site. A transient membrane binding facilitated by the N-terminal α0 of 
DHDDS results in a conformational change that would displace the N-terminal coil from the 
hydrophobic tunnel to allow for the chain elongation process. Following several rounds of IPP 
condensations (~ 13 isoprene units), the hydrophobic tail of the product is pushed out of the 
tunnel thereby allowing the incorporation of additional isoprene units. The EKE insert at the α3 
helix may provide the appropriate flexibility as the product extends outside the tunnel. The 
resulting enzyme: product complex is destabilized by membrane binding, consequently leading 
to product release. To facilitate this process, the enzyme may undergo another conformational 
change through the α3 helix on DHDDS, which becomes less kinked to increase the size of the 
tunnel. Clearly, the model proposed herein suggests that subtle environmental changes can affect 
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the stability of the enzyme: product complex, leading to the observed product distribution in 
heteromeric enzymes. In the case of extensively long cis-PTases such as rubber synthase, 
additional players might provide incredible stability for the enzyme in its product-bounded form. 
This notion was previously supported by earlier studies on rubber synthase, demonstrating the 
requirement of other components including a rubber particle, a rubber elongation factor (REF), 
and several small stabilizing proteins (SRPP) (56).  
Given the essential role of protein glycosylation for various cellular functions, mutations 
on both NgBR and DHDDS subunits have been associated with serious human diseases. 
Determining the crystal structure of the complex allowed us to map and structurally analyze 
these mutations, many of which clustered around the active site region. An exception is the 
Parkinson’s disease mutations as most of them scatter throughout NgBR structure and do not 
seem to influence protein folding or dimerization. Therefore, the molecular mechanism 
underlying their etiology remains unclear. However, one Parkinson’s mutation, G91C, is located 
within the N-terminal helix of NgBR and seems to indirectly influence cis-PTase activity by 
disrupting the C-terminal -RXG- motif involved in catalysis and substrate binding. In addition, 
our structure provides the first insight into the molecular mechanism of K42E, the most 
commonly occurring mutation among Ashkenazi Jewish patients diagnosed with the autosomal 
recessive retinitis pigmentosa. We show that a mutation at this position disrupts a conserved salt 
bridge formed with Glu-233 and could perturb DHDDS’s α1 helix involved in FPP binding, 
consistent with our previous functional studies on the purified mutant (9). It is important to note 
that in most cases, the disease severity in patients harboring cis-PTase mutations correlates well 
with their genotype and their measured enzymatic activity. For instance, the homozygous R290H 
mutation associated with the severe, multi-systemic CDG type I, displayed only ~20% cis-PTase 
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activity when measured from patients’ fibroblasts as well as the purified mutant (9, 39). In 
contrast, heterozygous mutations associated with the less severe developmental and epileptic 
encephalopathy (DEE) displayed up to 60% activity in fibroblasts with purified mutants being up 
to ~10% active. An exception is the K42E mutation which results in a marked reduction in cis-
PTase activity (enzyme was ~15% active), yet patients with this homozygous mutation displayed 
a non-syndromic retinitis pigmentosa with no obvious defects in other tissues and organs. A 
recent genetic model of mice with a global knock-in of the homozygous K42E mutation showed 
a marked gliosis with no evidence of retinal degeneration or defective protein N-glycosylation in 
retinal tissues (100). Furthermore, selective ablation of DHHD in retinal tissues of mice showed 
a profound and rapid retinal degradation, again with no effect on protein N-glycosylation (101, 
102). In another genetic study using zebrafish as a  model, it was shown that a global knockdown 
of DHDDS resulted in the loss of photoreceptor outer segment and visual function (103). 
Collectively, these studies suggest that the pathology of retinitis pigmentosa might not be 
mediated by a defective protein glycosylation process and that it may involve other unknow 
functions of dolichols. As mentioned earlier, patients harboring the homozygous R290H also 
develop retinitis pigmentosa. Intriguingly, in both K42E and R290H patients, an aberrant 
dolichol ratio was observed whereby Dol-18 became the dominant polyprenol instead of Dol-19 
(39, 66). It is possible that toxic accumulation of these aberrant dolichols might cause a retinal 
damage. However, there is no current evidence demonstrating the precise effect of aberrant 
dolichol chain length on cellular functions. 
Clearly, the structural work presented in this dissertation is the first attempt in the field to 
gain an insight into molecular mechanism of heteromeric cis-PTases. The structure reveals many 
novel aspects regarding the heteromeric assembly of the two subunits and proposes a rational 
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model for the mechanism of chain elongation. Moreover, our structural-functional analysis of 
NgBR/DHDDS disease mutations provides a framework to better understand the molecular 
mechanism underlying their pathogenicity and might aid in the development of new therapeutic 
strategies that could delay the progression of some clinical symptoms associated with these 
mutations. Future work might involve a structural characterization of NgBR N-terminal region 
harboring the predicted membrane-binding domains to better understand its membrane topology. 
Previous work demonstrated the presence of a signal anchor consisting of the first 23 amino 
acids at the N-terminus of NgBR (45). Therefore, this region might serve as an important 
component in the selection mechanism for ER localization. To gain an insight into the structure 
of the N-terminus, one strategy might involve a reconstitution of the full length NgBR/DHDDS 
complex into nanodiscs with appropriate size and lipid composition, followed by a structural 
analysis using cryo-EM technique. Another important structural feature that demands further 
investigation is the newly identified N-terminal region of DHDDS. Results presented in this 
work suggest a possible conformational change induced by phospholipid binding; such a 
conformational change involves the displacement of the N-terminal coil containing a bulky Trp-
3. To further test this model, future studies might involve fluorescence binding experiment to 
monitor changes in fluorescence of Trp-3 upon adding phospholipids. An alternative approach 
might involve a hydrogen-deuterium exchange mass spectroscopy (HDX-MS) analysis in the 
presence and absence of phospholipids.  
In addition, our knowledge regarding regulation of cis-PTase activity is still limited 
despite its crucial role in protein glycosylation. Interestingly, recent studies revealed that some 
homodimeric cis-PTase enzymes can utilize dimethyl allyl pyrophosphate (DMAPP) as the 
homoallylic substrate to catalyze a head-to-middle condensation reaction, leading to the 
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formation of branched isoprenoids. Our preliminary data on the purified human complex showed 
that although the enzyme failed to use DMAPP as the homoallylic substrate to catalyze the 
reaction, a slight enhancement in cis-PTase activity was observed upon adding DMAPP at low 
concentrations in the presence of enzyme’s substrates. Recent work by Zhao et.al (77) suggested 
a possible binding site for a farnesylated Ras at the NgBR subunit. Accordingly, we hypothesize 
that this region might serve as an allosteric binding site for the regulation of enzymatic activity 
by small molecules. Therefore, one possible follow-up experiment might involve solving the 
crystal structure of NgBR/DHDDS in complex with DMAPP to better understand its role in 
enzyme activation. Besides allosteric activation, inhibiting cis-PTase activity could be another 
interesting field to explore due to the decent amount of work showing an altered NgBR 
expression in cancerous tissue, which might result in changes in cis-PTase activity. Moreover, 
the bacterial UPPS has been a common target for the development of new and effective 
antibacterial drugs. Nevertheless, one important issue that may halt the development of many of 
these drugs is their specificity in targeting the bacterial rather than the human enzyme. Therefore, 
with our newly solved structure, it might be possible to virtually screen thousands of compounds 
against the human enzyme which will narrow down the number of molecules with inhibitory 
effect and could potentially accelerate the development of hit molecules. In summary, the 
structural work presented in this dissertation is the first attempt in the field to decipher the 
molecular mechanism of a heteromeric cis-PTase enzyme and serves as a framework for future 



















Figure S1. De novo synthesis of dolichol from FPP and IPP. 
 
Cis-PTase catalyzes the condensation of farnesyl pyrophosphate with multiple isopentenyl 
pyrophosphate molecules, resulting in the formation of polyprenol pyrophosphate. The 
condensation is followed by dephosphorylation and reduction to form dolichol, which is further 
phosphorylated by a dolichol kinase to yield dolichol phosphate, the main sugar carrier lipid during 
















Figure S2. Structural details of the NgBR subunit. 
 
(A) Ribbon diagram of NgBR/DHDDS complex; NgBR colored in orange and DHDDS in deep 
teal. The N-terminal helix of NgBR is colored in gray and the C-terminal loop in red. Secondary 
structure elements as well as N- and C-termini of NgBR are labeled on the structure.  
(B) 2Fo-Fc electron density map of the C-terminal -RXG- motif of NgBR contoured at 1.0 σ. The 
motif residues are indicated by the asterisks. 
(C) Partial amino acid sequence of NgBR subunit (residues 79-293) is aligned with partial 
sequence of yeast NUS1 subunit (residues 148-375). Numbers and secondary structure elements 
shown above the sequence correspond to that of NgBR. NUS1 secondary structure elements are 
















Figure S3. Structural details of the DHDDS subunit. 
 
(A) Ribbon diagram of NgBR/DHDDS complex; NgBR colored in orange, DHDDS in deep teal. 
The N-terminal region of DHDDS is colored red and the C-terminal helices are in gray. Secondary 
structure elements as well as N- and C-termini of NgBR are labeled on the structure.  
(B) 2Fo-Fc electron density map of the C-terminal helices of DHDDS contoured at 1.0 σ. Residues 
mutated in the yeast complementation experiment are labeled in red.  
(C) The full-length amino acid sequence of DHDDS subunit (residues 1-333) is aligned with full 
length E.coli UPPS (residues 1-253). Numbers and secondary structure elements shown above the 
sequence correspond to that of DHDDS. E.coli UPPS secondary structure elements are shown in 













Figure S4. Structural comparison of NgBR, Nus1 and UPPS. 
 
A ribbon diagram comparing the structure of (A) NgBR (orange) to that of (B) yeast Nus1 (Ruby, 
PDB ID 6JCN) and (C) UPPS (Purple, PDB ID 4H8E). NgBR possesses α4 helix, which differs 
from that of UPPS and is replaced by βC and βC’ in Nus1. An additional α1 helix is present in 


















Figure S5. Active site comparison of NgBR, DHDDS and UPPS. 
 
A ribbon diagram highlighting the hydrophobic cavity of NgBR (orange), DHDDS (cyan) and 
UPPS (pink). NgBR exhibits a short α3 helix, which directly associates with α2 helix, leading to 
the collapse of the active site cavity. Such architecture may account for the inability of NgBR to 





















Figure S6. The final 2Fo-Fc map surrounding the bound ligands.  
 
The electron density is contoured at 1.0 σ level. The oxygen atoms are colored red and phosphorus 
atoms are colored orange. The carbon atoms of IPP1 are colored salmon and those of IPP2 are in 
green. DHDDS residues involved in catalysis and substrate binding are shown in cyan, while those 











Figure S7. Comparison of different dimeric structures.  
 
(A) Ribbon diagram of the heteromeric complex is shown. NgBR is colored in orange, and 
DHDDS is colored in deep teal. The heteromeric structure is compared with those of yeast NUS1 
dimer (PDB 6JCN) colored in orange and E. coli UPPS (PDB 1X06) colored in deep teal. 
(B) NgBR (orange) is superimposed on yeast NUS1 (gray) (C  RMSD 1.8 Å). Wireframe diagram 
of Cα atoms is shown.  












Figure S8. Limited proteolysis of NgBR/DHDDS complex. 
 
Purified protein complex was incubated with increasing concentrations of proteinase k (A) or 
trypsin (B) (0.005, 0.01, 0.02, 0.04, 0.08, 0.16 mg/ml). Untreated protein sample is denoted as (U) 
and the location of proteinase k is indicated by the asterisks. The time course of degradation 
observed with both proteases is similar to that with thermolysin shown in fig.2B whereby NgBR 

















Figure S9. The dimeric interphase between NgBR and DHDDS.  
  
(A) A top view of the heteromeric complex. The dimeric interface has a surface area of 2,029 Å2. 
NgBR is colored in orange and DHDDS in deep teal. 
(B) The position of the NgBR mutations described in Fig. 2B. I200A, L226A, L230A, G252A, 
F253A and P255A are most disruptive to dimerization, which is consistent with their location 
within the canonical dimer interface. The side chains of Lys-197 and Asp-248 participate in 
hydrogen-bonding across the dimer interface. Ile-263 and Gly-292 participate in hydrophobic 
contacts across the interface. However, K197A, D248A, I263A and G292A have a relatively small 
effect, suggesting that these interactions do not contribute significantly to dimer stability. Based 
on the bacterial UPPS structure, Gln-180 was predicted to also fall within the dimer interface. 
However, as revealed by the new heteromeric structure, this residue is distal to the interface, which 
explains why Q180A has no effect on dimerization. The remaining four mutations affect residues 
that are near the interface but do not directly contact DHDDS. G196A alters the packing of the 
interfacial 5 helix and thus influences dimer stability indirectly. The other three mutations 













Figure S10. The complete binding interactions for IPP1 and IPP2.   
 
2D representations of the binding interactions for IPP1 (A) and IPP2 (B) are shown (1). Nitrogen 
atoms are colored blue, oxygen atoms in red, carbon atoms in black and water molecules in 
turquoise. Phosphorus atoms and bonds of both ligands are shown in purple and non-ligand bonds 






















Figure S11. Structural comparison of the S1 site.   
 
The S1 site involved in the binding of allylic substrate is compared among different cis-PTases 
including human NgBR/DHDDS complex, cis-PTase from tomato, denoted as zFPS (PDB ID 
5HXP), S. aureus UPPS denoted as SaUPPS (PDB ID 4H8E) and isosesquilavandulyl diphosphate 
synthase denoted as ISLPPS (PDB ID 5XK6). Mg2+ ion is shown as gray sphere, conserved 
residues involved in binding of allylic pyrophosphate are colored in cyan and labeled, and 
hydrogen bonds are shown as black-dashed lines. Oxygen atoms are colored red, phosphorus atoms 
are in orange and nitrogen are in blue. The carbon atoms of the allylic substrate are shown in 
salmon and those for the homoallylic substrate are shown in green. His-51 in the human 
NgBR/DHDDS complex is sometimes replaced with tyrosine; in both cases, the side chain is 
involved in hydrogen bonding with α phosphate of the allylic substrate. His-50 in SaUPPS can 
















Figure S12. Structural comparison of the S2 site.   
 
The S2 site involved in the binding of homoallylic substrate is compared among different cis-
PTases including human NgBR/DHDDS complex, cis-PTase from E.coli UPPS, denoted as 
EcUPPS (PDB ID 1X06), M. tuberculosis UPPS Rv2361c denoted as MlDPPS (PDB ID 6IME) 
and isosesquilavandulyl diphosphate synthase denoted as ISLPPS (PDB ID 5XK9). Mg2+ ion is 
shown as gray sphere, conserved C-terminal -RXG- residues from NgBR and other corresponding 
monomers are colored in yellow while those for DHDDS are in cyan. Hydrogen bonds are shown 
as black-dashed lines. Oxygen atoms are colored red, phosphorus atoms are in orange and nitrogen 
atoms are in blue. The carbon atoms of the allylic substrate are shown in salmon and those for the 
homoallylic substrate are shown in green. The disordered -RXG- motif in EcUPPS results in an 










Figure S13. Missense mutations associated with CDG.  
 
(A) CDG-causing NgBR and DHDDS mutations are indicated as purple spheres on the structure. 
NgBR is colored in orange and DHDDS in gray. The CDG mutations cluster around the active site 
of the complex. In DHDDS, those include: Arg-37, Arg-38, Lys-42, Thr-206, and Arg-211. In 
NgBR, Arg-290 is part of the conserved C-terminal -RXG- motif. 
(B) The side chain of Thr-206 is involved in hydrogen bonding (shown as dashed lines) with the 
backbone amide and carbonyl of Asp-34. The carbon atoms are colored deep teal, nitrogen atoms 
colored blue and oxygen atoms colored red. IPP1 colored red, IPP2 colored green and the Mg2+ is 


















Figure S14. De novo DHDDS mutations associated with neurodegenerative disorder 
(A) DHDDS mutations are indicated as purple spheres on the structure. NgBR is colored in orange 
and DHDDS in gray. Most of the mutations cluster around the active site of the complex, including 
S213N, R211Q, R205Q, G35E, P233R and R37H/C. An exception is I135T, which is distal to the 
active site.  
(B) The side chain of R37 is involved in a network of interactions with the pyrophosphate moiety 
of the allylic substrate, the side chain of a conserved E89 on DHDDS, and the main chain amide 
of K293 from NgBR C-terminal region. The carbon atoms are colored deep teal, nitrogen atoms 
colored blue and oxygen atoms colored red. IPP1 colored red, IPP2 colored green and the Mg2+ is 
shown as a gray sphere.   
(C) Side chains of R205, R211 and S213 are depicted at the S2 site, and are involved in salt 
bridging and hydrogen bonding with the pyrophosphate group of IPP substrate. Replacement of 
Arg residues with Gln will eliminate these salt bridges and thus weaken IPP binding. Substituting 
Ser with Asn might result in steric clashes with nearby residues, thereby destabilizing the structure.  
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(D) Ribbon diagram showing the side chain of P233 is involved in hydrophobic packing against 
Y39, which is located at α1 helix known to harbor residues important for FPP binding. A P233R 























Figure S15. Plausible catalytic mechanism of the human NgBR/DHDDS complex 
The synthesis of polyprenol pyrophosphate is initiated with the binding of FPP to the empty S1 
site, followed by binding of Mg2+-IPP complex to the S2 site. Two conformational changes might 
occur at this point: the first involves the α3 helix, which becomes more kinked to enhance 
hydrophobic interactions with the substrates. A second conformational change might involve a 
transient membrane binding facilitated by DHDDS α0 helix which will displace its N-terminal coil 
from the hydrophobic cavity between α2 and α3, rendering it accessible for chain elongation. After 
several rounds of condensations (~13 isoprene units incorporated), the product is extended outside 
the tunnel, thereby allowing the condensation of 6 more isoprene units. As the product becomes 
exposed, interaction with ER membrane will further destabilize the enzyme : product complex, 
hence facilitating product release. At this stage, another conformational change involving α3 helix 








Table S1. Crystallographic statistics. The NgBR/DHDDS heterodimer was crystallized in 
space group R32. 
 
Data Collection  
Wavelength, Å 0.979 
Cell Dimensions, Å a=b=185.7, c=113.4 
aResolution (Å) 40-2.3 (2.38-2.30)  
Redundancy 14.7 (4.5) 
Completeness (%) 95.0 (74.5) 
<I>/<σ> 17.4 (0.9) 
CC1/2 0.997 (0.473) 
a,bRpim 0.036 (0.549) 
Refinement    
Unique reflections 29,756 
Number of Atoms 4,036 
    Protein 3,901 
    Ligand 29 
    Solvent 106 
cRwork/Rfree 0.212/0.255 
Mean B-value (Å2) 78.8 
    Protein 79.0 
    Ligand 66.5 
    Solvent 75.2 
r.m.s. deviations  
    Bond lengths (Å) 0.004 
    Bond angles (°) 1.133 
dRamachandran (f, a, o) 96%, 4%, 0% 
PDB accession code 6W2L 
 








1. Crowell DN & Huizinga DH (2009) Protein isoprenylation: the fat of the matter. Trends 
Plant Sci 14(3):163-170. 
 
2. Grabińska KA, Park EJ, & Sessa WC (2016) cis-Prenyltransferase: New Insights into 
Protein Glycosylation, Rubber Synthesis, and Human Diseases. J Biol Chem 
291(35):18582-18590. 
 
3. Lange BM, Rujan T, Martin W, & Croteau R (2000) Isoprenoid biosynthesis: The 
evolution of two ancient and distinct pathways across genomes. Proceedings of the 
National Academy of Sciences 97(24):13172-13177. 
 
4. Nowicka B & Kruk J (2010) Occurrence, biosynthesis and function of isoprenoid 
quinones. Biochim Biophys Acta 1797(9):1587-1605. 
 
5. Santner A, Calderon-Villalobos LIA, & Estelle M (2009) Plant hormones are versatile 
chemical regulators of plant growth. Nature Chemical Biology 5(5):301-307. 
 
6. Takahashi S & Koyama T (2006) Structure and function of cis-prenyl chain elongating 
enzymes. Chem Rec 6(4):194-205. 
 
7. Miziorko HM (2011) Enzymes of the mevalonate pathway of isoprenoid biosynthesis. 
Arch Biochem Biophys 505(2):131-143. 
 
8. Rohmer M, Grosdemange-Billiard C, Seemann M, & Tritsch D (2004) Isoprenoid 
biosynthesis as a novel target for antibacterial and antiparasitic drugs. Curr Opin Investig 
Drugs 5(2):154-162. 
 
9. Grabińska KA, Edani BH, Park EJ, Kraehling JR, & Sessa WC (2017) A conserved C-
terminal RXG motif in the NgBR subunit of cis-prenyltransferase is critical for 
prenyltransferase activity. J Biol Chem 292(42):17351-17361. 
 
10. Chen C-C, et al. (2020) Versatile cis-isoprenyl Diphosphate Synthase Superfamily 
Members in Catalyzing Carbon–Carbon Bond Formation. ACS Catalysis 10(8):4717-
4725. 
 
11. Koyama T (1999) Molecular analysis of prenyl chain elongating enzymes. Biosci 
Biotechnol Biochem 63(10):1671-1676. 
 
12. Shimizu N, Koyama T, & Ogura K (1998) Molecular cloning, expression, and 
purification of undecaprenyl diphosphate synthase. No sequence similarity between E- 




13. Teng KH & Liang PH (2012) Structures, mechanisms and inhibitors of undecaprenyl 
diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis. 
Bioorg Chem 43:51-57. 
 
14. Apfel CM, Takács B, Fountoulakis M, Stieger M, & Keck W (1999) Use of genomics to 
identify bacterial undecaprenyl pyrophosphate synthetase: cloning, expression, and 
characterization of the essential uppS gene. J Bacteriol 181(2):483-492. 
 
15. Sato M, et al. (1999) The yeast RER2 gene, identified by endoplasmic reticulum protein 
localization mutations, encodes cis-prenyltransferase, a key enzyme in dolichol synthesis. 
Mol Cell Biol 19(1):471-483. 
 
16. Ogawa T, Emi K-i, Koga K, Yoshimura T, & Hemmi H (2016) A cis-prenyltransferase 
from Methanosarcina acetivorans catalyzes both head-to-tail and nonhead-to-tail prenyl 
condensation. The FEBS Journal 283(12):2369-2383. 
 
17. Liu M, et al. (2016) Structure and Function of a "Head-to-Middle" Prenyltransferase: 
Lavandulyl Diphosphate Synthase. Angew Chem Int Ed Engl 55(15):4721-4724. 
 
18. Ozaki T, Zhao P, Shinada T, Nishiyama M, & Kuzuyama T (2014) Cyclolavandulyl 
Skeleton Biosynthesis via Both Condensation and Cyclization Catalyzed by an 
Unprecedented Member of the cis-Isoprenyl Diphosphate Synthase Superfamily. Journal 
of the American Chemical Society 136(13):4837-4840. 
 
19. Cunillera N, Arró M, Forés O, Manzano D, & Ferrer A (2000) Characterization of 
dehydrodolichyl diphosphate synthase of Arabidopsis thaliana, a key enzyme in dolichol 
biosynthesis. FEBS Lett 477(3):170-174. 
 
20. Endo S, Zhang Y-W, Takahashi S, & Koyama T (2003) Identification of human 
dehydrodolichyl diphosphate synthase gene. Biochimica et Biophysica Acta (BBA) - Gene 
Structure and Expression 1625(3):291-295. 
 
21. Oh SK, Han KH, Ryu SB, & Kang H (2000) Molecular cloning, expression, and 
functional analysis of a cis-prenyltransferase from Arabidopsis thaliana. Implications in 
rubber biosynthesis. J Biol Chem 275(24):18482-18488. 
 
22. Shridas P, Rush JS, & Waechter CJ (2003) Identification and characterization of a cDNA 
encoding a long-chain cis-isoprenyltranferase involved in dolichyl monophosphate 
biosynthesis in the ER of brain cells. Biochem Biophys Res Commun 312(4):1349-1356. 
 
23. Buczkowska A, Swiezewska E, & Lefeber DJ (2015) Genetic defects in dolichol 
metabolism. J Inherit Metab Dis 38(1):157-169. 
 
24. Concha N, et al. (2016) Discovery and Characterization of a Class of Pyrazole Inhibitors 





25. Jukič M, Rožman K, Sova M, Barreteau H, & Gobec S (2019) Anthranilic Acid 
Inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an Essential Enzyme for 
Bacterial Cell Wall Biosynthesis. Frontiers in Microbiology 9:3322. 
 
26. Farha MA, et al. (2015) Antagonism screen for inhibitors of bacterial cell wall biogenesis 
uncovers an inhibitor of undecaprenyl diphosphate synthase. Proc Natl Acad Sci U S A 
112(35):11048-11053. 
 
27. Guo R-T, et al. (2007) Bisphosphonates target multiple sites in both <em>cis</em>- and 
<em>trans</em>-prenyltransferases. Proceedings of the National Academy of Sciences 
104(24):10022-10027. 
 
28. Zhu W, et al. (2013) Antibacterial drug leads targeting isoprenoid biosynthesis. 
Proceedings of the National Academy of Sciences 110(1):123-128. 
 
29. Akhtar TA, et al. (2013) The tomato cis-prenyltransferase gene family. Plant J 
73(4):640-652. 
 
30. Grabińska KA, et al. (2010) Molecular characterization of the cis-prenyltransferase of 
Giardia lamblia. Glycobiology 20(7):824-832. 
 
31. Hemmi H, Yamashita S, Shimoyama T, Nakayama T, & Nishino T (2001) Cloning, 
Expression, and Characterization of<em>cis</em>-Polyprenyl Diphosphate Synthase 
from the Thermoacidophilic Archaeon <em>Sulfolobus acidocaldarius</em>. Journal of 
Bacteriology 183(1):401-404. 
 
32. Kaur D, Brennan PJ, & Crick DC (2004) Decaprenyl diphosphate synthesis in 
Mycobacterium tuberculosis. J Bacteriol 186(22):7564-7570. 
 
33. Löw P, et al. (1991) The mevalonate pathway in the bloodstream form of Trypanosoma 
brucei. Identification of dolichols containing 11 and 12 isoprene residues. J Biol Chem 
266(29):19250-19257. 
 
34. Schilmiller AL, et al. (2009) Monoterpenes in the glandular trichomes of tomato are 
synthesized from a neryl diphosphate precursor rather than geranyl diphosphate. 
Proceedings of the National Academy of Sciences 106(26):10865-10870. 
 
35. Schulbach MC, Brennan PJ, & Crick DC (2000) Identification of a short (C15) chain Z-
isoprenyl diphosphate synthase and a homologous long (C50) chain isoprenyl 
diphosphate synthase in Mycobacterium tuberculosis. J Biol Chem 275(30):22876-22881. 
 
36. Taguchi Y, Fujinami D, & Kohda D (2016) Comparative Analysis of Archaeal Lipid-
linked Oligosaccharides That Serve as Oligosaccharide Donors for Asn Glycosylation. J 




37. Brasher MI, et al. (2015) A two-component enzyme complex is required for dolichol 
biosynthesis in tomato. Plant J 82(6):903-914. 
 
38. Emi K-i, Sompiyachoke K, Okada M, & Hemmi H (2019) A heteromeric cis-
prenyltransferase is responsible for the biosynthesis of glycosyl carrier lipids in 
Methanosarcina mazei. Biochemical and Biophysical Research Communications 
520(2):291-296. 
 
39. Park EJ, et al. (2014) Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, 
causes a congenital disorder of glycosylation. Cell Metab 20(3):448-457. 
 
40. Epping J, et al. (2015) A rubber transferase activator is necessary for natural rubber 
biosynthesis in dandelion. Nature Plants 1(5):15048. 
 
41. Qu Y, et al. (2015) A lettuce (Lactuca sativa) homolog of human Nogo-B receptor 
interacts with cis-prenyltransferase and is necessary for natural rubber biosynthesis. J 
Biol Chem 290(4):1898-1914. 
 
42. Sato M, Fujisaki S, Sato K, Nishimura Y, & Nakano A (2001) Yeast Saccharomyces 
cerevisiae has two cis-prenyltransferases with different properties and localizations. 
Implication for their distinct physiological roles in dolichol synthesis. Genes Cells 
6(6):495-506. 
 
43. Schenk B, Rush JS, Waechter CJ, & Aebi M (2001) An alternative cis-
isoprenyltransferase activity in yeast that produces polyisoprenols with chain lengths 
similar to mammalian dolichols. Glycobiology 11(1):89-98. 
 
44. Miao RQ, et al. (2006) Identification of a receptor necessary for Nogo-B stimulated 
chemotaxis and morphogenesis of endothelial cells. Proceedings of the National 
Academy of Sciences 103(29):10997-11002. 
 
45. Harrison KD, et al. (2009) Nogo-B receptor stabilizes Niemann-Pick type C2 protein and 
regulates intracellular cholesterol trafficking. Cell Metab 10(3):208-218. 
 
46. Harrison KD, et al. (2011) Nogo-B receptor is necessary for cellular dolichol 
biosynthesis and protein N-glycosylation. EMBO J 30(12):2490-2500. 
 
47. Kwon M, Kwon EJG, & Ro DK (2016) Chapter Six - cis-Prenyltransferase and Polymer 
Analysis from a Natural Rubber Perspective. Methods in Enzymology, ed O'Connor SE 
(Academic Press), Vol 576, pp 121-145. 
 
48. Fujihashi M, et al. (2001) Crystal structure of <em>cis</em>-prenyl chain elongating 





49. Chan Y-T, et al. (2017) Crystal Structure and Potential Head-to-Middle Condensation 
Function of a Z,Z-Farnesyl Diphosphate Synthase. ACS Omega 2(3):930-936. 
 
50. Guo RT, et al. (2005) Crystal structures of undecaprenyl pyrophosphate synthase in 
complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: 
roles of the metal ion and conserved residues in catalysis. J Biol Chem 280(21):20762-
20774. 
 
51. Wang W, et al. (2008) The structural basis of chain length control in Rv1086. J Mol Biol 
381(1):129-140. 
 
52. Chang SY, Ko TP, Liang PH, & Wang AH (2003) Catalytic mechanism revealed by the 
crystal structure of undecaprenyl pyrophosphate synthase in complex with sulfate, 
magnesium, and triton. J Biol Chem 278(31):29298-29307. 
 
53. Kharel Y, Zhang Y-W, Fujihashi M, Miki K, & Koyama T (2001) Identification of 
Significant Residues for Homoallylic Substrate Binding of Micrococcus luteus B-P 26 
Undecaprenyl Diphosphate Synthase. Journal of Biological Chemistry 276(30):28459-
28464. 
 
54. Pan J-J, Yang L-W, & Liang P-H (2000) Effect of Site-Directed Mutagenesis of the 
Conserved Aspartate and Glutamate on E. coli Undecaprenyl Pyrophosphate Synthase 
Catalysis. Biochemistry 39(45):13856-13861. 
 
55. Lisnyansky Bar-El M, et al. (2019) Structural Characterization of Full-Length Human 
Dehydrodolichyl Diphosphate Synthase Using an Integrative Computational and 
Experimental Approach. Biomolecules 9(11). 
 
56. Yamashita S, et al. (2016) Identification and reconstitution of the rubber biosynthetic 
machinery on rubber particles from Hevea brasiliensis. Elife 5. 
 
57. Lakusta AM, et al. (2019) Molecular Studies of the Protein Complexes Involving Cis-
Prenyltransferase in Guayule (Parthenium argentatum), an Alternative Rubber-Producing 
Plant. Frontiers in Plant Science 10(165). 
 
58. Emi KI, Sompiyachoke K, Okada M, & Hemmi H (2019) A heteromeric cis-
prenyltransferase is responsible for the biosynthesis of glycosyl carrier lipids in 
Methanosarcina mazei. Biochem Biophys Res Commun 520(2):291-296. 
 
59. Den K, et al. (2019) Recurrent NUS1 canonical splice donor site mutation in two 
unrelated individuals with epilepsy, myoclonus, ataxia and scoliosis - a case report. BMC 
Neurology 19(1):253. 
 
60. Hamdan FF, et al. (2017) High Rate of Recurrent De Novo Mutations in Developmental 




61. Sabry S, et al. (2016) A case of fatal Type I congenital disorders of glycosylation (CDG 
I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity. 
Orphanet J Rare Dis 11(1):84. 
 
62. Zelinger L, et al. (2011) A missense mutation in DHDDS, encoding dehydrodolichyl 
diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in 
Ashkenazi Jews. Am J Hum Genet 88(2):207-215. 
 
63. Züchner S, et al. (2011) Whole-exome sequencing links a variant in DHDDS to retinitis 
pigmentosa. Am J Hum Genet 88(2):201-206. 
 
64. Gao J, et al. (2018) "Head-to-Middle" and "Head-to-Tail" cis-Prenyl Transferases: 
Structure of Isosesquilavandulyl Diphosphate Synthase. Angew Chem Int Ed Engl 
57(3):683-687. 
 
65. Ko TP, et al. (2019) Substrate-analogue complex structure of Mycobacterium 
tuberculosis decaprenyl diphosphate synthase. Acta Crystallogr F Struct Biol Commun 
75(Pt 4):212-216. 
 
66. Wen R, Lam BL, & Guan Z (2013) Aberrant dolichol chain lengths as biomarkers for 
retinitis pigmentosa caused by impaired dolichol biosynthesis. J Lipid Res 54(12):3516-
3522. 
 
67. Steward CA, et al. (2019) Re-annotation of 191 developmental and epileptic 
encephalopathy-associated genes unmasks de novo variants in SCN1A. npj Genomic 
Medicine 4(1):31. 
 
68. Milani D, et al. (2016) Insights into 6q21-q22: Refinement of the critical region for acro-
cardio-facial syndrome. Congenital Anomalies 56(4):187-189. 
 
69. Szafranski P, et al. (2015) 6q22.1 microdeletion and susceptibility to pediatric epilepsy. 
Eur J Hum Genet 23(2):173-179. 
 
70. Guo JF, et al. (2018) Coding mutations in NUS1 contribute to Parkinson's disease. Proc 
Natl Acad Sci U S A 115(45):11567-11572. 
 
71. PULA B, et al. (2014) Nogo-B Receptor Expression Correlates Negatively with 
Malignancy Grade and Ki-67 Antigen Expression in Invasive Ductal Breast Carcinoma. 
Anticancer Research 34(9):4819-4828. 
 
72. Wang B, et al. (2013) Expression of NgBR is highly associated with estrogen receptor 
alpha and survivin in breast cancer. PLoS One 8(11):e78083. 
 
73. Zhang R, Tang BS, & Guo JF (2020) Research advances on neurite outgrowth inhibitor B 




74. Zhao B, et al. (2015) Comprehensive proteome quantification reveals NgBR as a new 
regulator for epithelial-mesenchymal transition of breast tumor cells. J Proteomics 
112:38-52. 
 
75. Banerjee DK (2012) N-glycans in cell survival and death: cross-talk between 
glycosyltransferases. Biochim Biophys Acta 1820(9):1338-1346. 
 
76. Janik ME, Lityńska A, & Vereecken P (2010) Cell migration-the role of integrin 
glycosylation. Biochim Biophys Acta 1800(6):545-555. 
 
77. Zhao B, et al. (2017) The Nogo-B receptor promotes Ras plasma membrane localization 
and activation. Oncogene 36(24):3406-3416. 
 
78. Gao P, et al. (2018) Nogo-B receptor increases the resistance to tamoxifen in estrogen 
receptor-positive breast cancer cells. Breast Cancer Research 20(1):112. 
 
79. Jin Y, et al. (2018) Nogo-B receptor increases the resistance of estrogen receptor positive 
breast cancer to paclitaxel. Cancer Lett 419:233-244. 
 
80. PULA B, et al. (2014) Expression of Nogo Isoforms and Nogo-B Receptor (NgBR) in 
Non-small Cell Lung Carcinomas. Anticancer Research 34(8):4059-4068. 
 
81. Wu D, et al. (2018) Nogo-B receptor promotes epithelial-mesenchymal transition in non-
small cell lung cancer cells through the Ras/ERK/Snail1 pathway. Cancer Lett 418:135-
146. 
 
82. Park EJ, Grabińska KA, Guan Z, & Sessa WC (2016) NgBR is essential for endothelial 
cell glycosylation and vascular development. EMBO Rep 17(2):167-177. 
 
83. Zhao B, et al. (2010) Nogo-B receptor is essential for angiogenesis in zebrafish via Akt 
pathway. Blood 116(24):5423-5433. 
 
84. Ma J, et al. (2019) Structural insights to heterodimeric cis-prenyltransferases through 
yeast dehydrodolichyl diphosphate synthase subunit Nus1. Biochem Biophys Res 
Commun 515(4):621-626. 
 
85. Otwinowski Z & Minor W (1997) [20] Processing of X-ray diffraction data collected in 
oscillation mode. Methods in Enzymology,  (Academic Press), Vol 276, pp 307-326. 
 
86. Winn MD, et al. (2011) Overview of the CCP4 suite and current developments. Acta 
Crystallogr D Biol Crystallogr 67(Pt 4):235-242. 
 
87. Emsley P, Lohkamp B, Scott WG, & Cowtan K (2010) Features and development of 




88. Holcomb J, et al. (2018) SAXS analysis of a soluble cytosolic NgBR construct including 
extracellular and transmembrane domains. PLoS One 13(1):e0191371. 
 
89. Malwal SR, et al. (2018) Catalytic Role of Conserved Asparagine, Glutamine, Serine, 
and Tyrosine Residues in Isoprenoid Biosynthesis Enzymes. ACS Catalysis 8(5):4299-
4312. 
 
90. Kimchi A, et al. (2018) Nonsyndromic Retinitis Pigmentosa in the Ashkenazi Jewish 
Population: Genetic and Clinical Aspects. Ophthalmology 125(5):725-734. 
 
91. Fedorow H, et al. (2005) Dolichol is the major lipid component of human substantia 
nigra neuromelanin. J Neurochem 92(4):990-995. 
 
92. Ward WC, et al. (2007) Identification and quantification of dolichol and dolichoic acid in 
neuromelanin from substantia nigra of the human brain. J Lipid Res 48(7):1457-1462. 
 
93. Cherian S, Ryu SB, & Cornish K (2019) Natural rubber biosynthesis in plants, the rubber 
transferase complex, and metabolic engineering progress and prospects. Plant Biotechnol 
J 17(11):2041-2061. 
 
94. Hoffmann R, Grabińska K, Guan Z, Sessa WC, & Neiman AM (2017) Long-Chain 
Polyprenols Promote Spore Wall Formation in Saccharomyces cerevisiae. Genetics 
207(4):1371-1386. 
 
95. Voss NR & Gerstein M (2010) 3V: cavity, channel and cleft volume calculator and 
extractor. Nucleic Acids Res 38(Web Server issue):W555-562. 
 
96. CHEN Annie P-C, et al. (2005) Substrate and product specificities of cis-type 
undecaprenyl pyrophosphate synthase. Biochemical Journal 386(1):169-176. 
 
97. Chen YH, Chen AP, Chen CT, Wang AH, & Liang PH (2002) Probing the 
conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during 
catalysis using an inhibitor and tryptophan mutants. J Biol Chem 277(9):7369-7376. 
 
98. Ko TP, et al. (2001) Mechanism of product chain length determination and the role of a 
flexible loop in Escherichia coli undecaprenyl-pyrophosphate synthase catalysis. J Biol 
Chem 276(50):47474-47482. 
 
99. Bar-El ML, et al. (2020) Structural basis of heterotetrameric assembly and disease 
mutations in the human cis-prenyltransferase complex. Nat Commun 11(1):5273-5273. 
 
100. Fliesler SJ, Kotla P, Ramachandra Rao S, & Pittler SJ (2019) Lack of overt pathology in 
a K42E knock-in mouse model of retinitis pigmentosa (RP59). Investigative 




101. DeRamus ML, et al. (2020) Selective Ablation of Dehydrodolichyl Diphosphate 
Synthase in Murine Retinal Pigment Epithelium (RPE) Causes RPE Atrophy and Retinal 
Degeneration. Cells 9(3):771. 
 
102. Ramachandra Rao S, et al. (2020) Retinal Degeneration Caused by Rod-Specific Dhdds 
Ablation Occurs without Concomitant Inhibition of Protein N-Glycosylation. iScience 
23(6):101198. 
 
103. Wen R, et al. (2014) Knock-down DHDDS expression induces photoreceptor 




INFORMATION TO ALL USERS 
The quality and completeness of this reproduction is dependent on the quality  
and completeness of the copy made available to ProQuest. 
Distributed by ProQuest LLC (        ). 
Copyright of the Dissertation is held by the Author unless otherwise noted. 
This work may be used in accordance with the terms of the Creative Commons license 
or other rights statement, as indicated in the copyright statement or in the metadata  
associated with this work. Unless otherwise specified in the copyright statement  
or the metadata, all rights are reserved by the copyright holder. 
This work is protected against unauthorized copying under Title 17, 
United States Code and other applicable copyright laws. 
Microform Edition where available © ProQuest LLC. No reproduction or digitization  
of the Microform Edition is authorized without permission of ProQuest LLC. 
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, MI 48106 - 1346 USA 
28318918
2021
